International Journal international I In Int Inte BLOCKSTART PAGESTART NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
Molecular Sciences molecular M Mo Mol Mole BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 1 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
Article Article article A Ar Art Arti BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
Synthesis, Antitumor synthesis, S Sy Syn Synt BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 9 1 0 0 0 1
Modeling and modeling M Mo Mod Mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 - 1 9 1 0 0 0 1
Relationship (QSAR) relationship R Re Rel Rela BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ()-[(--- 8 9 1 0 0 0 1
N-substituted-1,3,5-triazin-2-yl)methylthio]-4- N-substituted-1,3,5-triazin-2-yl)methylthio]-4- n-substituted-1,3,5-triazin-2-yl)methylthio]-4- N N- N-s N-su BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 --,,---)]-- 11 10 1 0 0 0 1
chloro-5-methyl-N-(1H-benzo[d]imidazol-2(3H)- chloro-5-methyl-N-(1H-benzo[d]imidazol-2(3H)- chloro-5-methyl-n-(1h-benzo[d]imidazol-2(3h)- c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 ----(-[]-()- 12 9 1 0 0 0 1
ylidene)Benzenesulfonamides ylidene)Benzenesulfonamides ylidene)benzenesulfonamides y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ) 1 5 1 0 0 0 1
Łukasz Tomorowicz łukasz Ł Łu Łuk Łuka BLOCKSTART PAGEIN SAMEFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ,,*,,*, 7 10 0 0 0 0 1
Krzysztof Szafra krzysztof K Kr Krz Krzy BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 no 0 5 0 0 0 0 1
1 1 1 1 1 1 1 BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 1 no 0 10 0 0 0 0 1
Department of department D De Dep Depa BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 1 ,,...,-, 8 10 0 0 0 0 1
Poland; ltomorowicz@gumed.edu.pl poland; P Po Pol Pola BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ;@..(..);.@..(..) 17 7 0 0 0 0 1
2 2 2 2 2 2 2 BLOCKSTART PAGEIN SAMEFONT LOWERFONT 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 2 no 0 10 0 0 0 0 1
Department of department D De Dep Depa BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,, 2 10 0 0 0 0 1
University of university U Un Uni Univ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,.,-,;.@... 11 8 0 0 0 0 1
* Correspondence: * * * * * BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 2 *:@..(..);@..(..); 18 7 0 0 0 0 1
Tel.: +48-58-349-10-98 tel.: T Te Tel Tel. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 .:----(..);----(..) 19 5 0 0 0 0 1
Received: 19 received: R Re Rec Rece BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 3 :;:;: 5 10 0 0 0 0 1
Abstract: A abstract: A Ab Abs Abst BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 :-[(----,,---)]------(- 23 9 0 0 0 0 1
R 1 r R R R R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 0 4 --[]-()-)- 10 9 0 0 0 0 1
of 5-substituted of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -----[-(---[]-()-)]-- 21 9 0 0 0 0 1
methylphenylthio}acetate with methylphenylthio}acetate m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ., 2 9 0 0 0 0 1
22 and 22 2 22 22 22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 0 4 ,(-), 5 9 0 0 0 0 1
(MCF-7) and (mcf-7) ( (M (MC (MCF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 4 (-)()(:-;--),. 14 10 0 0 0 0 1
Further QSAR further F Fu Fur Furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 (-) 3 9 0 0 0 0 1
investigated compounds investigated i in inv inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 -,- 3 8 0 0 0 0 1
topological (2D) topological t to top topo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ()() 4 9 0 0 0 0 1
regression technique regression r re reg regr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 (). 3 9 0 0 0 0 1
predictive models predictive p pr pre pred BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 ., 2 9 0 0 0 0 1
the possible the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 4 ,, 2 9 0 0 0 0 1
MDM2 protein. mdm2 M MD MDM MDM2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 4 . 1 1 0 0 0 0 1
Keywords: benzenesulfonamide; keywords: K Ke Key Keyw BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 :;;,,-;;; 9 10 0 1 0 0 1
1. Introduction 1. 1 1. 1. 1. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 8 . 1 10 0 1 0 0 1
Cancer is cancer C Ca Can Canc BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 no 0 8 0 1 0 0 1
developed nations. developed d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 .,, 3 8 0 1 0 0 1
rectum in rectum r re rec rect BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 8 ,,[]. 5 8 0 1 0 0 1
cancer treatment cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 ,. 2 9 0 1 0 0 1
effort in effort e ef eff effo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 , 1 10 0 1 0 0 1
as compared as a as as as BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 []. 3 3 0 1 0 0 1
The mouse/murine the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 /,,-, 5 8 0 1 0 0 1
important negative important i im imp impo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 [,]., 5 9 0 1 0 0 1
MDM2 protein mdm2 M MD MDM MDM2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 8 , 1 9 0 1 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 11 ....,,;:./ 10 10 0 0 0 0 1
www.mdpi.com/journal/ijms www.mdpi.com/journal/ijms www.mdpi.com/journal/ijms w ww www www. BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 ..// 4 4 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ....,, 6 10 0 0 1 1 1
2 of 2 2 2 2 2 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 0 0 0 0 1
DNA for dna D DN DNA DNA BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 .,/ 3 8 1 1 0 0 1
normal and normal n no nor norm BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 [,].,, 6 9 1 1 0 0 1
overexpressed and overexpressed o ov ove over BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 -,, 3 9 1 1 0 0 1
survival and survival s su sur surv BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 [-]./ 5 9 1 1 0 0 1
interaction may interaction i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 0 --[]. 5 9 1 1 0 0 1
Hence, small hence, H He Hen Henc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 ,/ 2 9 1 1 0 0 1
level of level l le lev leve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 []. 3 5 1 1 0 0 1
The nutlins the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 -, 2 9 1 1 0 0 1
by Vassilev by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 .- 2 9 1 1 0 0 1
p53-binding pocket, p53-binding p p5 p53 p53- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 -,[]. 5 10 1 1 0 0 1
molecule belonging molecule m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 --, 3 9 1 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ()., 4 9 1 1 0 0 1
and in and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,-,, 4 9 1 1 0 0 1
retinoblastoma, prostate retinoblastoma, r re ret reti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 ,,,[]. 6 9 1 1 0 0 1
promising compounds, promising p pr pro prom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 ,, 2 9 1 1 0 0 1
further chemical further f fu fur furt BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 0 . 1 3 1 1 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 2 ....,, 6 10 0 0 0 0 1
2 of 2 2 2 2 2 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 2 no 0 1 0 0 0 0 1
blocking the blocking b bl blo bloc BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 /-- 3 8 1 1 0 0 1
type tumor type t ty typ type BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 [].,/ 5 9 1 1 0 0 1
lead to lead l le lea lead BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 []. 3 7 1 1 0 0 1
The nutlins the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 -, 2 9 1 1 0 0 1
by Vassilev by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 .- 2 9 1 1 0 0 1
p53-binding pocket, p53-binding p p5 p53 p53- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 2 -,[]. 5 10 1 1 0 0 1
molecule belonging molecule m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 --, 3 8 1 1 0 0 1
enantiomer of enantiomer e en ena enan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 ()., 4 9 1 1 0 0 1
both in both b bo bot both BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ,- 2 9 1 1 0 0 1
cancer, melanoma, cancer, c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 ,,,,,[]. 8 9 1 1 0 0 1
The nutlins the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 ,, 2 9 1 1 0 0 1
structures for structures s st str stru BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 . 1 4 1 1 0 0 1
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 4 .-- 3 7 1 1 0 0 1
mercaptobenzenosulfonamide fragment mercaptobenzenosulfonamide m me mer merc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 4 . 1 10 1 1 0 0 1
2-mercaptobenzenosulfonamide fragment 2-mercaptobenzenosulfonamide 2 2- 2-m 2-me BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 4 -. 2 9 1 1 0 0 1
Our previous our O Ou Our Our BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 , 1 8 1 1 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ',- 3 9 1 1 0 0 1
fragment for fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 ,. 2 9 1 1 0 0 1
proved that proved p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 9 1 1 0 0 1
more active more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 , 1 9 1 1 0 0 1
with potential with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 9 1 1 0 0 1
various targets various v va var vari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 . 1 9 1 1 0 0 1
In this in I In In In BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 0 5 ,-[(----,,---)]----- 20 9 1 1 0 0 1
methyl-N-(5-R 1 methyl-n-(5-r m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 --(---[]-()-) 13 9 1 1 0 0 1
hybrids combining hybrids h hy hyb hybr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -( 2 9 1 1 0 0 1
1). In 1). 1 1) 1). 1). BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 5 )., 3 9 1 1 0 0 1
their impact their t th the thei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -. 2 10 1 1 0 0 1
tested for tested t te tes test BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 5 -,-. 4 7 1 1 0 0 1
2. Results 2. 2 2. 2. 2. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 . 1 10 0 0 0 0 1
2.1. Chemistry 2.1. 2 2. 2.1 2.1. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 .. 2 10 0 0 0 0 1
The starting the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 ------,,-(),-[--- 17 9 0 0 0 0 1
(N-cyanosulfamoyl)-4-methylphenylthio]acetate potassium (n-cyanosulfamoyl)-4-methylphenylthio]acetate ( (N (N- (N-c BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 (-)--]()[], 11 9 0 0 0 0 1
hydrochlorides, were hydrochlorides, h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 ,[-].- 6 9 0 0 0 0 1
synthesized analogously synthesized s sy syn synt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 ---,-. 6 10 0 0 0 0 1
Finally Finally finally F Fi Fin Fina BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 7 no 0 0 0 0 0 0 1
2-[(4-amino-6-R 2 2-[(4-amino-6-r 2 2- 2-[ 2-[( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 -[(----,,---)]----- 19 6 0 0 0 0 1
-N-(5-R 1 -n-(5-r - -N -N- -N-( BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 --(--- 6 1 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)benzenesulfonamides (6-49) benzo[d]imidazol-2(3h)-ylidene)benzenesulfonamides b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 7 []-()-)(-) 10 9 0 0 0 0 1
esters 3-5 esters e es est este BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 7 -/ 2 9 0 0 0 0 1
hours. hours. hours. h ho hou hour BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 7 . 1 0 0 0 0 0 1
Figure 1. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 8 .-- 3 10 1 1 0 0 1
fragment and fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 .- 2 9 1 1 0 0 1
fragment and fragment f fr fra frag BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 8 . 1 5 1 1 0 0 1
Our previous our O Ou Our Our BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 9 , 1 8 1 1 0 0 1
carried out carried c ca car carr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ',- 3 9 1 1 0 0 1
fragment for fragment f fr fra frag BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 ,. 2 9 1 1 0 0 1
proved that proved p pr pro prov BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 . 1 9 1 1 0 0 1
more active more m mo mor more BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 , 1 9 1 1 0 0 1
with potential with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 . 1 9 1 1 0 0 1
for various for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 no 0 9 1 1 0 0 1
MDM2. In mdm2. M MD MDM MDM2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 9 .,-[(----,,---)]- 17 9 1 1 0 0 1
-4-chloro-5-methyl-N-(5-R 1 -4-chloro-5-methyl-n-(5-r - -4 -4- -4-c BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 9 ------(---[]-()-) 17 9 1 1 0 0 1
molecular hybrids molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 - 1 8 1 1 0 0 1
ring (Figure ring r ri rin ring BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 0 9 ()., 4 9 1 1 0 0 1
to investigate to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 -. 2 10 1 1 0 0 1
compounds were compounds c co com comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 9 -,-. 4 9 1 1 0 0 1
2. Results 2. 2 2. 2. 2. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 . 1 10 0 0 0 0 1
2.1. Chemistry 2.1. 2 2. 2.1 2.1. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 .. 2 10 0 0 0 0 1
The starting the T Th The The BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 11 ------,,-(),-[-- 16 9 0 0 0 0 1
2-(N-cyanosulfamoyl)-4-methylphenylthio]acetate potassium 2-(n-cyanosulfamoyl)-4-methylphenylthio]acetate 2 2- 2-( 2-(N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 11 -(-)--]()[], 12 10 0 0 0 0 1
hydrochlorides, were hydrochlorides, h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 11 ,[-].- 6 9 0 0 0 0 1
synthesized analogously synthesized s sy syn synt BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 11 ---,-. 6 10 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 0 ....,, 6 10 1 1 1 0 1
3 of 3 3 3 3 3 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 0 no 0 10 1 1 0 0 1
Finally 2-[(4-amino-6-R finally F Fi Fin Fina BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 0 -[(----,,---)]------(---[]- 27 10 1 1 0 0 1
2(3H)-ylidene)benzenesulfonamides (6-49) 2(3h)-ylidene)benzenesulfonamides 2 2( 2(3 2(3H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 0 ()-)(-)- 8 9 1 1 0 0 1
biguanide hydrochlorides biguanide b bi big bigu BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 0 /. 2 6 1 1 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 0 1 ....,, 6 10 1 1 0 0 1
3 of 3 3 3 3 3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 0 1 no 0 1 1 1 0 0 1
Scheme 1. scheme S Sc Sch Sche BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 2 .-----[-(---[]-()- 18 8 1 1 0 0 1
ylidene)sulfamoyl]-4-methylphenylthio}acetate ylidene)sulfamoyl]-4-methylphenylthio}acetate ylidene)sulfamoyl]-4-methylphenylthio}acetate y yl yli ylid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 2 )]-- 4 4 1 1 0 0 1
3-5 3-5 3-5 3 3- 3-5 3-5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 2 - 1 0 1 1 0 0 1
and and and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 0 2 no 0 0 1 1 0 0 1
[(4-amino-6-R 2 [(4-amino-6-r [ [( [(4 [(4- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 2 [(----,,--- 11 3 1 1 0 0 1
yl)methylthio]-4-chloro-5-methyl-N-(5-R 1 yl)methylthio]-4-chloro-5-methyl-n-(5-r y yl yl) yl)m BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 2 )]------(---[]-()-) 19 8 1 1 0 0 1
6-49. Reagents 6-49. 6 6- 6-4 6-49 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 0 2 -.:()(..),,, 12 9 1 1 0 0 1
reflux 5 reflux r re ref refl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 0 2 ;()---,-(..),,. 15 10 1 1 0 0 1
The final the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 ( 1 8 1 1 0 0 1
Supplementary Materials) supplementary S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 0 5 ). 2 10 1 1 0 0 1
(C, H, (c, ( (C (C, (C, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 0 5 (,,). 5 7 1 1 0 0 1
Scheme 1. scheme S Sc Sch Sche BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 .-----[-(---[]-()- 18 8 1 1 0 0 1
ylidene)sulfamoyl]-4-methylphenylthio}acetate 3-5 ylidene)sulfamoyl]-4-methylphenylthio}acetate y yl yli ylid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 )]---[(----,,---)]-- 20 9 1 1 0 0 1
chloro-5-methyl-N-(5-R 1 chloro-5-methyl-n-(5-r c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 ----(---[]-()-)-. 17 8 1 1 0 0 1
and conditions: and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 :()(..),,,;() 13 10 1 1 0 0 1
appropriate 4-R appropriate a ap app appr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ---,-(..),,. 12 8 1 1 0 0 1
The final the T Th The The BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 ( 1 8 1 1 0 0 1
Supplementary Materials) supplementary S Su Sup Supp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 ).(, 4 9 1 1 0 0 1
H, N) h, H H, H, H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 8 ,). 3 6 1 1 0 0 1
For example, for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 8 ,--,,- 6 9 1 1 0 0 1
the benzimidazole the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 -.-. 4 10 1 1 0 0 1
at 10.5-12.15 at a at at at BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 8 .-.,.-- 7 9 1 1 0 0 1
7.61-7.94 and 7.61-7.94 7 7. 7.6 7.61 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 8 .-..-.,,-. 10 9 1 1 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ....,, 6 10 0 0 1 0 1
4 of 4 4 4 4 4 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 0 0 0 0 1
2.2. Cytotoxic 2.2. 2 2. 2.2 2.2. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 .. 2 10 0 0 0 0 1
Compounds 6-49 compounds C Co Com Comp BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 8 0 1 0 0 1
cancer cell cancer c ca can canc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 :-(),-()() 10 9 0 1 0 0 1
the non-cancerous the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -(). 4 10 0 1 0 0 1
viability IC viability v vi via viab BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 , 1 10 0 1 0 0 1
Table 1. table T Ta Tab Tabl BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 . 1 0 0 1 0 0 1
Table 1. table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 1 .--. 4 10 0 1 0 0 1
Compd Compd compd C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 5 0 1 0 0 1
IC 50 ic I IC IC IC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 1 [] 2 10 0 1 0 0 1
HCT-116 HCT-116 hct-116 H HC HCT HCT- BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 - 1 10 0 1 0 0 1
MCF-7 MCF-7 mcf-7 M MC MCF MCF- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 - 1 7 0 1 0 0 1
HeLa HeLa hela H He HeL HeLa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 6 0 1 0 0 1
HaCaT HaCaT hacat H Ha HaC HaCa BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 1 0 0 1
6 6 6 6 6 6 6 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 2 0 0 0 0 1
49 ± 49 4 49 49 49 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
52 ± 52 5 52 52 52 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
50 ± 50 5 50 50 50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
57 ± 57 5 57 57 57 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
7 7 7 7 7 7 7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 2 0 0 0 0 1
75 ± 75 7 75 75 75 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
99 ± 99 9 99 99 99 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
86 ± 86 8 86 86 86 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
102 ± 102 1 10 102 102 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 8 0 0 0 0 1
8 8 8 8 8 8 8 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 2 0 0 0 0 1
23 ± 23 2 23 23 23 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
34 ± 34 3 34 34 34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
31 ± 31 3 31 31 31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
43 ± 43 4 43 43 43 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
9 9 9 9 9 9 9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 no 0 2 0 0 0 0 1
25 ± 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
20 ± 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
23 ± 23 2 23 23 23 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
42 ± 42 4 42 42 42 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
32 ± 32 3 32 32 32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
25 ± 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
30 ± 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
45 ± 45 4 45 45 45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
37 ± 37 3 37 37 37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
41 ± 41 4 41 41 41 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
39 ± 39 3 39 39 39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
58 ± 58 5 58 58 58 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
36 ± 36 3 36 36 36 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
36 ± 36 3 36 36 36 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
43 ± 43 4 43 43 43 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
32 ± 32 3 32 32 32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
41 ± 41 4 41 41 41 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
54 ± 54 5 54 54 54 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
41 ± 41 4 41 41 41 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
56 ± 56 5 56 56 56 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
65 ± 65 6 65 65 65 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
22 ± 22 2 22 22 22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
27 ± 27 2 27 27 27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
92 ± 92 9 92 92 92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
NT * nt N NT NT NT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 * 1 5 0 0 0 0 1
33 ± 33 3 33 33 33 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
32 ± 32 3 32 32 32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
33 ± 33 3 33 33 33 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
45 ± 45 4 45 45 45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
29 ± 29 2 29 29 29 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
31 ± 31 3 31 31 31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
30 ± 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
43 ± 43 4 43 43 43 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
42 ± 42 4 42 42 42 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
82 ± 82 8 82 82 82 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
61 ± 61 6 61 61 61 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
84 ± 84 8 84 84 84 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
15 ± 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
19 ± 19 1 19 19 19 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
18 ± 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
31 ± 31 3 31 31 31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
16 ± 16 1 16 16 16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
15 ± 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
32 ± 32 3 32 32 32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
11 ± 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
11 ± 11 1 11 11 11 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
34 ± 34 3 34 34 34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
16 ± 16 1 16 16 16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
20 ± 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
27 ± 27 2 27 27 27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
42 ± 42 4 42 42 42 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
16 ± 16 1 16 16 16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
46 ± 46 4 46 46 46 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
28 ± 28 2 28 28 28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
52 ± 52 5 52 52 52 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
20 ± 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
21 ± 21 2 21 21 21 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
110 ± 110 1 11 110 110 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 8 0 0 0 0 1
74 ± 74 7 74 74 74 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
98 ± 98 9 98 98 98 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
16 ± 16 1 16 16 16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
195 ± 195 1 19 195 195 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 8 0 0 0 0 1
134 ± 134 1 13 134 134 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 8 0 0 0 0 1
56 ± 56 5 56 56 56 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
NT * nt N NT NT NT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 * 1 5 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
18 ± 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
36 ± 36 3 36 36 36 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
18 ± 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
46 ± 46 4 46 46 46 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
39 ± 39 3 39 39 39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
54 ± 54 5 54 54 54 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
280 ± 280 2 28 280 280 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 9 0 0 0 0 1
137 ± 137 1 13 137 137 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 8 0 0 0 0 1
250 ± 250 2 25 250 250 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 9 0 0 0 0 1
NT * nt N NT NT NT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 1 * 1 5 0 0 0 0 1
19 ± 19 1 19 19 19 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
30 ± 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
48±2 48±2 48±2 4 48 48± 48±2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 no 0 5 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
25 ± 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
30 ± 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
41 ± 41 4 41 41 41 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
37 ± 37 3 37 37 37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
40 ± 40 4 40 40 40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
39 ± 39 3 39 39 39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
52 ± 52 5 52 52 52 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
18 ± 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 . 1 9 0 0 0 0 1
37 ± 37 3 37 37 37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
29 ± 29 2 29 29 29 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
49 ± 49 4 49 49 49 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
17 ± 17 1 17 17 17 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
27 ± 27 2 27 27 27 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
20 ± 20 2 20 20 20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
39 ± 39 3 39 39 39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
14±1 14±1 14±1 1 14 14± 14±1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 no 0 5 0 0 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
18 ± 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
38 ± 38 3 38 38 38 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
35±2 35±2 35±2 3 35 35± 35±2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 no 0 5 0 0 0 0 1
74 ± 74 7 74 74 74 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
28 ± 28 2 28 28 28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
76 ± 76 7 76 76 76 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
16 ± 16 1 16 16 16 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
43 ± 43 4 43 43 43 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
18 ± 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
46 ± 46 4 46 46 46 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
25 ± 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
38 ± 38 3 38 38 38 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
30 ± 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
49 ± 49 4 49 49 49 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
18 ± 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
23 ± 23 2 23 23 23 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
37 ± 37 3 37 37 37 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
43 ± 43 4 43 43 43 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
44 ± 44 4 44 44 44 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
45 ± 45 4 45 45 45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
55 ± 55 5 55 55 55 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
48 ± 48 4 48 48 48 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
47 ± 47 4 47 47 47 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
50 ± 50 5 50 50 50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
61 ± 61 6 61 61 61 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
15 ± 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
26 ± 26 2 26 26 26 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
28 ± 28 2 28 28 28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
39 ± 39 3 39 39 39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
7 ± 7 7 7 7 7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 1 . 1 8 0 0 0 0 1
15 ± 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
18 ± 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
28 ± 28 2 28 28 28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
21 ± 21 2 21 21 21 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
22 ± 22 2 22 22 22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
38 ± 38 3 38 38 38 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
34 ± 34 3 34 34 34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
32 ± 32 3 32 32 32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
34 ± 34 3 34 34 34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
40 ± 40 4 40 40 40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
30 ± 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
34 ± 34 3 34 34 34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
96 ± 96 9 96 96 96 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 1 no 0 7 0 0 0 0 1
cisplatin cisplatin cisplatin c ci cis cisp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 1 no 0 10 0 0 0 0 1
2.2 ± 2.2 2 2. 2.2 2.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 .. 2 10 0 0 0 0 1
3.0 ± 3.0 3 3. 3.0 3.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 .. 2 10 0 0 0 0 1
3.8 ± 3.8 3 3. 3.8 3.8 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 1 .. 2 10 0 0 0 0 1
NT*-not tested. nt*-not N NT NT* NT*- BLOCKSTART PAGEEND NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 11 *-. 3 10 0 1 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ....,, 6 10 0 1 1 0 1
5 of 5 5 5 5 5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 0 no 0 10 0 1 0 0 1
Cell lines: cell C Ce Cel Cell BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 :(-),(-),(), 12 8 1 0 0 0 1
keratinocyte cell keratinocyte k ke ker kera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 ();-;,,,, 9 9 1 0 0 0 1
100 µM. 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 .. 2 8 1 0 0 0 1
The most the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 - 1 6 1 0 0 0 1
(R 2 (r ( (R (R (R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 ([-(-)--](, 11 8 1 0 0 0 1
18 µM, 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 ,)-,- 5 9 1 0 0 0 1
HaCaT/HCT-116 and hacat/hct-116 H Ha HaC HaCa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 /-/-()., 8 8 1 0 0 0 1
to the to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ([-(-)--] 9 9 1 0 0 0 1
HCT-116 and hct-116 H HC HCT HCT- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 -()/- 5 9 1 0 0 0 1
equal to equal e eq equ equa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .(). 4 2 1 0 0 0 1
As shown as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 ,- 2 8 1 0 0 0 1
was affected was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -,,,,,,,,,, 11 9 1 0 0 0 1
IC 50 ic I IC IC IC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 1 0 ., 2 9 1 0 0 0 1
(19-23, 30, (19-23, ( (1 (19 (19- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 (-,,,)-,-(,, 12 9 1 0 0 0 1
and 46) and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ). 2 5 1 0 0 0 1
We found we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 0 -, 2 7 1 0 0 0 1
of R of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ----(,),-(---(),-(- 19 7 1 0 0 0 1
chlorophenylpiperazin-1-yl (23) chlorophenylpiperazin-1-yl c ch chl chlo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 --() 4 9 1 0 0 0 1
lines with lines l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -, 2 9 1 0 0 0 1
(R 2 (r ( (R (R (R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 (---)(-()--) 12 9 1 0 0 0 1
caused a caused c ca cau caus BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 -()(-) 6 10 1 0 0 0 1
32 (Table 32 3 32 32 32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 0 (). 3 9 1 0 0 0 1
1,3,5-triazine ring 1,3,5-triazine 1 1, 1,3 1,3, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 0 ,,--,--,,(--) 13 9 1 0 0 0 1
or anilino or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 (-) 3 9 1 0 0 0 1
(IC 50 (ic ( (I (IC (IC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 0 (-),-(-) 8 9 1 0 0 0 1
for 34 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 ,.,(-) 6 8 1 0 0 0 1
benzylamino group benzylamino b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 0 (-).--, 7 8 1 0 0 0 1
well as well w we wel well BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 0 .--(). 6 5 1 0 0 0 1
45 45 45 4 45 45 45 BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 3 0 1 0 0 1
15 ± 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
26 ± 26 2 26 26 26 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
28 ± 28 2 28 28 28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
39 ± 39 3 39 39 39 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
46 46 46 4 46 46 46 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 3 0 1 0 0 1
7 ± 7 7 7 7 7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 1 5 . 1 8 0 1 0 0 1
15 ± 15 1 15 15 15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
18 ± 18 1 18 18 18 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
28 ± 28 2 28 28 28 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
47 47 47 4 47 47 47 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 3 0 1 0 0 1
21 ± 21 2 21 21 21 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
24 ± 24 2 24 24 24 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
22 ± 22 2 22 22 22 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
38 ± 38 3 38 38 38 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
48 48 48 4 48 48 48 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 3 0 1 0 0 1
34 ± 34 3 34 34 34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
32 ± 32 3 32 32 32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
34 ± 34 3 34 34 34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
40 ± 40 4 40 40 40 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
49 49 49 4 49 49 49 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 3 0 1 0 0 1
30 ± 30 3 30 30 30 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
35 ± 35 3 35 35 35 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
34 ± 34 3 34 34 34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
96 ± 96 9 96 96 96 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 5 no 0 7 0 1 0 0 1
cisplatin cisplatin cisplatin c ci cis cisp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 5 no 0 10 0 1 0 0 1
2.2 ± 2.2 2 2. 2.2 2.2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .. 2 10 0 1 0 0 1
3.0 ± 3.0 3 3. 3.0 3.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .. 2 10 0 1 0 0 1
3.8 ± 3.8 3 3. 3.8 3.8 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 5 .. 2 10 0 1 0 0 1
NT* -not nt* N NT NT* NT* BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 *-. 3 10 0 1 0 0 1
Cell lines: cell C Ce Cel Cell BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 :(-),(-),(), 12 8 1 0 0 0 1
keratinocyte cell keratinocyte k ke ker kera BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 ();-;,,,, 9 9 1 0 0 0 1
100 µM. 100 1 10 100 100 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 1 6 .. 2 8 1 0 0 0 1
The most the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 -([-(- 6 8 1 0 0 0 1
fluorophenyl)piperazin-1-yl] and fluorophenyl)piperazin-1-yl] f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 )--](,, 7 8 1 0 0 0 1
respectively) against respectively) r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 )-,- 4 8 1 0 0 0 1
HaCaT/HCT-116 and hacat/hct-116 H Ha HaC HaCa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 /-/-()., 8 8 1 0 0 0 1
belonged to belonged b be bel belo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ([-(-)--] 9 9 1 0 0 0 1
inhibited HCT-116 inhibited i in inh inhi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -()/- 5 9 1 0 0 0 1
or HeLa or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .(). 4 3 1 0 0 0 1
As shown as A As As As BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 ,- 2 8 1 0 0 0 1
was affected was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -,,,,,,,,,, 11 10 1 0 0 0 1
values from values v va val valu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .,(- 4 9 1 0 0 0 1
23, 30, 23, 2 23 23, 23, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 ,,,)-,-(,, 10 9 1 0 0 0 1
46) with 46) 4 46 46) 46) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 ). 2 4 1 0 0 0 1
We found we W We We We BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 1 6 -,-- 4 8 1 0 0 0 1
piperazin-1-yl (19, piperazin-1-yl p pi pip pipe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 --(,),-(---(),-(---() 21 9 1 0 0 0 1
substituents provided substituents s su sub subs BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 1 6 no 0 9 1 0 0 0 1
range of range r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -,(---) 7 9 1 0 0 0 1
or phenylsulfonyl or o or or or BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 (-()--) 7 9 1 0 0 0 1
IC50 values ic50 I IC IC5 IC50 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 -()(-)(). 9 9 1 0 0 0 1
mentioned that mentioned m me men ment BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 ,,-- 4 9 1 0 0 0 1
17, 33-36 17, 1 17 17, 17, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 1 6 ,--,,(--) 9 9 1 0 0 0 1
(R 2 (r ( (R (R (R BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 1 6 (-)(-), 7 9 1 0 0 0 1
the same the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -(-), 5 8 1 0 0 0 1
respectively. On respectively. r re res resp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 .,(-) 5 8 1 0 0 0 1
group 15 group g gr gro grou BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 (-).--,.- 9 9 1 0 0 0 1
fold increase fold f fo fol fold BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 1 6 -(). 4 4 1 0 0 0 1
Figure 2. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 . 1 10 1 1 0 0 1
non-cancerous HaCaT non-cancerous n no non non- BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 11 -. 2 3 1 1 0 0 1
2.3. Quantitative 2.3. 2 2. 2.3 2.3. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 11 ..-() 5 10 1 1 0 0 1
Correlation between correlation C Co Cor Corr BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 . 1 9 1 1 0 0 1
Three-dimensional structures three-dimensional T Th Thr Thre BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 11 - 1 10 1 1 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 ()() 4 9 1 1 0 0 1
by geometry by b by by by BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 (). 3 9 1 1 0 0 1
of final of o of of of BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 11 . 1 9 1 1 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 ....,, 6 10 0 0 1 0 1
6 of 6 6 6 6 6 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 no 0 10 0 0 0 0 1
descriptors were descriptors d de des desc BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ., 2 9 0 1 0 0 1
progressive regression progressive p pr pro prog BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 8 0 1 0 0 1
removed from removed r re rem remo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (-,,,,,, 8 9 0 1 0 0 1
MCF-7 cell mcf-7 M MC MCF MCF- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 -,,,,). 7 6 0 1 0 0 1
The obtained the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 () 2 8 0 1 0 0 1
topological (2D) topological t to top topo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 ()(). 5 9 0 1 0 0 1
significant, they significant, s si sig sign BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ,- 2 10 0 1 0 0 1
usefulness of usefulness u us use usef BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 0 1 0 0 1
of Q of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (). 3 4 0 1 0 0 1
Table 2. table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 .. 2 10 0 1 0 0 1
Cell Line: cell C Ce Cel Cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 2 :- 2 10 0 1 0 0 1
IC 50 ic I IC IC IC BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 2 ...-. 5 9 0 1 0 0 1
15.724458 b_max1len 15.724458 1 15 15. 15.7 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 2 2 ..-. 4 5 0 1 0 0 1
R 2 r R R R R BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 2 .;.;(,).;.-;();() 17 10 0 1 0 0 1
Cell Line: cell C Ce Cel Cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 :- 2 10 0 1 0 0 1
IC 50 ic I IC IC IC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 3 -.... 5 9 0 1 0 0 1
PEOE_VSA+1 + peoe_vsa+1 P PE PEO PEOE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 3 .-.-. 5 7 0 1 0 0 1
R 2 r R R R R BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 3 .;.;(,).;.-;();() 17 10 0 1 0 0 1
Cell Line: cell C Ce Cel Cell BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 : 1 10 0 1 0 0 1
IC 50 ic I IC IC IC BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 2 4 .-.-... 7 10 0 1 0 0 1
0.547602 SlogP_VSA5 0.547602 0 0. 0.5 0.54 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 .-. 3 2 0 1 0 0 1
R 2 r R R R R BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 4 .;.;(,).;.-;();() 17 8 0 1 0 0 1
R 2 r R R R R BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 2 5 -;-.;-'; 8 9 0 1 0 0 1
p-p-value for p-p-value p p- p-p p-p- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 --';()-;()-. 12 10 0 1 0 0 1
in the in i in in in BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 5 :-();- 6 8 0 1 0 0 1
element of element e el ele elem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 (,);--- 7 9 0 1 0 0 1
potential energy potential p po pot pote BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ();- 4 7 0 1 0 0 1
contribution to contribution c co con cont BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ()( 3 8 0 1 0 0 1
Distance Matrix distance D Di Dis Dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 );-( 4 8 0 1 0 0 1
descriptors); vsurf_IW6-hydrophilic descriptors); d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 );-(,);- 8 8 0 1 0 0 1
information content information i in inf info BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ()();- 6 9 0 1 0 0 1
range [0.05,0.10] range r ra ran rang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 [.,.]();-( 10 9 0 1 0 0 1
Surface Areas); surface S Su Sur Surf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 5 );-: 4 9 0 1 0 0 1
matrix of matrix m ma mat matr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 . 1 9 0 1 0 0 1
component axis. component c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 .(,);-- 7 8 0 1 0 0 1
violations (The violations v vi vio viol BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 ();-( 5 9 0 1 0 0 1
descriptors); b_1rotN-number descriptors); d de des desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 );-();- 7 9 0 1 0 0 1
strain energy strain s st str stra BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 5 (/):()( 7 9 0 1 0 0 1
log sum log l lo log log BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 5 -)();-(, 8 9 0 1 0 0 1
Descriptors); SlogP_VSA5-represent descriptors); D De Des Desc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 5 );-' 4 8 0 1 0 0 1
lipophilicity (The lipophilicity l li lip lipo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 5 (). 3 3 0 1 0 0 1
For each for F Fo For For BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 10 , 1 8 0 0 0 0 1
regression and regression r re reg regr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 ( 1 9 0 0 0 0 1
linearity, and linearity, l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 ,). 3 9 0 0 0 0 1
corresponded most corresponded c co cor corr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 :( 2 9 0 0 0 0 1
molecule) for molecule) m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 10 )-.,( 5 9 0 0 0 0 1
distance matrix distance d di dis dist BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 )-. 3 10 0 0 0 0 1
model there model m mo mod mode BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 ,' 2 9 0 0 0 0 1
contribution to contribution c co con cont BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 10 .. 2 6 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 ....,, 6 10 1 1 1 0 1
7 of 7 7 7 7 7 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 no 0 10 1 1 0 0 1
standard deviation standard s st sta stan BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 .(,); 5 9 1 1 0 0 1
-number of -number - -n -nu -num BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 0 --();- 6 9 1 1 0 0 1
fluorine atoms fluorine f fl flu fluo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ();-( 5 9 1 1 0 0 1
count and count c co cou coun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 );-(/) 6 10 1 1 0 0 1
into the into i in int into BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 :()(-)();- 10 9 1 1 0 0 1
principal moment principal p pr pri prin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (,);- 5 9 1 1 0 0 1
aspects of aspects a as asp aspe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 '(). 4 9 1 1 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 3 .() 3 10 1 1 0 0 1
and test and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 3 (). 3 1 1 1 0 0 1
From the from F Fr Fro From BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 4 -, 2 9 1 1 0 0 1
number of number n nu num numb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 4 (), 3 9 1 1 0 0 1
(pmi3), out-of-plane (pmi3), ( (p (pm (pmi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 (),--(),(), 11 10 1 1 0 0 1
hydrophilic integy hydrophilic h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 4 ()., 4 8 1 1 0 0 1
GCUT_SLOGP_1 shows gcut_slogp_1 G GC GCU GCUT BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 4 . 1 9 1 1 0 0 1
Figure 3. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 6 .() 3 10 1 1 0 0 1
and test and a an and and BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 6 (). 3 1 1 1 0 0 1
From the from F Fr Fro From BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 -, 2 9 1 1 0 0 1
of oxygen of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 (),(), 6 9 1 1 0 0 1
out-of-plane potential out-of-plane o ou out out- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 --(),(), 8 9 1 1 0 0 1
integy moment integy i in int inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 ()., 4 8 1 1 0 0 1
that the that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 . 1 10 1 1 0 0 1
compounds against compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 -.: 3 9 1 1 0 0 1
atom information atom a at ato atom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 ()(), 5 8 1 1 0 0 1
b_max1len, GCUT_SLOGP_2, b_max1len, b b_ b_m b_ma BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 7 ,,,. 4 8 1 1 0 0 1
HeLa model, hela H He HeL HeLa BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 7 , 1 9 1 1 0 0 1
parameters: the parameters: p pa par para BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 :()(). 6 9 1 1 0 0 1
Increased values increased I In Inc Incr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 7 (), 3 8 1 1 0 0 1
theory (h_pstrain), theory t th the theo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 7 (),(,) 6 9 1 1 0 0 1
anticancer activity anticancer a an ant anti BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 7 . 1 3 1 1 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 ....,, 6 10 0 1 1 0 1
8 of 8 8 8 8 8 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 2 0 no 0 10 0 1 0 0 1
2.4. Molecular 2.4. 2 2. 2.4 2.4. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 .. 2 10 0 1 0 0 1
In order in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 2 0 , 1 8 1 0 0 0 1
docking was docking d do doc dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 . 1 10 1 0 0 0 1
with good with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 , 1 9 1 0 0 0 1
a moderate a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 2 0 ,..,--[],[] 11 9 1 0 0 0 1
B-RAF [22] b-raf B B- B-R B-RA BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 2 0 -[][]. 6 6 1 0 0 0 1
Molecular docking molecular M Mo Mol Mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 2 0 no 0 8 1 0 0 0 1
MDM2 protein mdm2 M MD MDM MDM2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 no 0 9 1 0 0 0 1
using the using u us usi usin BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 (:).- 5 9 1 0 0 0 1
with Nutlin-3a. with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 -.(, 4 9 1 0 0 0 1
2018) software. 2018) 2 20 201 2018 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 2 0 ).-- 4 9 1 0 0 0 1
(Nutlin-3a) in (nutlin-3a) ( (N (Nu (Nut BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (-),-./ 7 9 1 0 0 0 1
standard deviation standard s st sta stan BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 0 ()..,,,, 8 9 1 0 0 0 1
Val93 in val93 V Va Val Val9 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 2 0 (). 3 4 1 0 0 0 1
cytotoxic activity cytotoxic c cy cyt cyto BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 -. 2 8 0 1 0 0 1
beneficial impacts beneficial b be ben bene BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 :()(), 6 9 0 1 0 0 1
which prefer which w wh whi whic BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 ,,, 3 8 0 1 0 0 1
favoring low favoring f fa fav favo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 ., 2 10 0 1 0 0 1
to higher to t to to to BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 :() 3 7 0 1 0 0 1
of rotatable of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 2 2 (). 3 9 0 1 0 0 1
counts (ast_violation), counts c co cou coun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 2 2 (),(), 6 9 0 1 0 0 1
(pmi, SlogP_VSA5) (pmi, ( (p (pm (pmi BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 2 2 (,). 4 6 0 1 0 0 1
2.4. Molecular 2.4. 2 2. 2.4 2.4. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 1 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 .. 2 10 0 1 0 0 1
In order in I In In In BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 3 , 1 8 1 0 0 0 1
docking was docking d do doc dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 . 1 10 1 0 0 0 1
with good with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 , 1 9 1 0 0 0 1
a moderate a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 3 ,..,--[],[]- 12 9 1 0 0 0 1
RAF [22] raf R RA RAF RAF BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 1 0 0 0 0 0 0 3 3 [][]. 5 6 1 0 0 0 1
Molecular docking molecular M Mo Mol Mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 no 0 8 1 0 0 0 1
MDM2 protein mdm2 M MD MDM MDM2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 no 0 8 1 0 0 0 1
investigated using investigated i in inv inve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 (:).- 5 9 1 0 0 0 1
crystalized with crystalized c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 -. 2 8 1 0 0 0 1
Environment (MOE, environment E En Env Envi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 3 (,).-- 6 9 1 0 0 0 1
crystallized ligand crystallized c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 (-),-. 6 9 1 0 0 0 1
kcal/mol and kcal/mol k kc kca kcal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 /()..,, 7 9 1 0 0 0 1
Gly58, Gln59, gly58, G Gl Gly Gly5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 ,,(). 5 6 1 0 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 .-(-) 5 10 1 1 0 0 1
of MDM2. of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .:-,-,-,-. 10 8 1 1 0 0 1
Docking of docking D Do Doc Dock BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 6 , 1 9 1 1 0 0 1
active site active a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (), 3 9 1 1 0 0 1
compounds as compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 .() 3 9 1 1 0 0 1
MDM2 inhibitors mdm2 M MD MDM MDM2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 . 1 9 1 1 0 0 1
Met62 located met62 M Me Met Met6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ., 2 9 1 1 0 0 1
compounds (22, compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 (,)- 4 9 1 1 0 0 1
and/or H-bond and/or a an and and/ BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 6 /-,- 4 9 1 1 0 0 1
MDM2 protein mdm2 M MD MDM MDM2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ().,-(---)-,,- 14 9 1 1 0 0 1
located in located l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 6 ,,,, 4 9 1 1 0 0 1
Gln59, interacting gln59, G Gl Gln Gln5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 6 ,()., 5 10 1 1 0 0 1
Figure 4. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 .-(-) 5 10 1 1 0 0 1
of MDM2. of o of of of BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 .:-,-,-,-. 10 8 1 1 0 0 1
Docking of docking D Do Doc Dock BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 , 1 8 1 1 0 0 1
active site active a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 (), 3 9 1 1 0 0 1
compounds as compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 .() 3 9 1 1 0 0 1
MDM2 inhibitors mdm2 M MD MDM MDM2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 . 1 9 1 1 0 0 1
and Met62 and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ., 2 9 1 1 0 0 1
active compounds active a ac act acti BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 (,)- 4 9 1 1 0 0 1
Leu54 and/or leu54 L Le Leu Leu5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 /-,- 4 9 1 1 0 0 1
the MDM2 the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ().,-(---)-,,- 14 10 1 1 0 0 1
located in located l lo loc loca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ,,,, 4 9 1 1 0 0 1
Gln59, interacting gln59, G Gl Gln Gln5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 8 ,()., 5 9 1 1 0 0 1
compounds 22 compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 , 1 9 1 1 0 0 1
binding pattern binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 (). 3 9 1 1 0 0 1
molecules, i.e., molecules, m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ,.., 4 9 1 1 0 0 1
the protein the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 ,,. 3 9 1 1 0 0 1
on the on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 -,--- 5 9 1 1 0 0 1
a key a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 8 -,,,- 5 9 1 1 0 0 1
responsible for responsible r re res resp BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 8 -()-(). 7 8 1 1 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ....,, 6 10 1 1 1 0 1
9 of 9 9 9 9 9 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 0 no 0 10 1 1 0 0 1
compounds 22 compounds c co com comp BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 , 1 9 1 1 0 0 1
binding pattern binding b bi bin bind BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 (). 3 9 1 1 0 0 1
molecules, i.e., molecules, m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,.., 4 9 1 1 0 0 1
of the of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 ,,. 3 10 1 1 0 0 1
on the on o on on on BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -,--- 5 9 1 1 0 0 1
a key a a a a a BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 1 0 1 0 0 0 0 0 3 0 -,,,- 5 9 1 1 0 0 1
responsible for responsible r re res resp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 0 -()-(). 7 8 1 1 0 0 1
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 3 .-(),() 7 10 1 0 0 0 1
46 inside 46 4 46 46 46 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 3 .:-,-, 6 9 1 0 0 0 1
hydrogen -grey, hydrogen h hy hyd hydr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 3 -,-,-. 6 6 1 0 0 0 1
Figure 5. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 .-(), 5 9 1 0 0 0 1
(B) 46 (b) ( (B (B) (B) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 ().:-,-, 8 10 1 0 0 0 1
hydrogen-grey, sulfur-yellow, hydrogen-grey, h hy hyd hydr BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 -,-,-. 6 6 1 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 1 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 6 ....,, 6 10 1 0 0 0 1
10 of 10 1 10 10 10 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 1 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 6 no 0 1 1 0 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 7 .,-() 5 10 1 0 0 0 1
site of site s si sit site BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 .:-,-,-,- 9 9 1 0 0 0 1
grey. grey. grey. g gr gre grey BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 7 . 1 0 1 0 0 0 1
Table 3. table T Ta Tab Tabl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 8 .,(:). 6 10 1 0 0 0 1
Compoun Compoun compoun C Co Com Comp BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 8 no 0 10 1 0 0 0 1
d d d d d d d BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 2 1 0 0 0 1
S S s S S S S BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 8 no 0 1 1 0 0 0 1
(kcal/mol) (kcal/mol) (kcal/mol) ( (k (kc (kca BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 8 (/) 3 10 1 0 0 0 1
Amino Amino amino A Am Ami Amin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 3 1 0 0 0 1
Acids Acids acids A Ac Aci Acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 3 1 0 0 0 1
Interacting Groups interacting I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
Type of type T Ty Typ Type BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 9 no 0 4 1 0 0 0 1
Interaction Interaction interaction I In Int Inte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 9 no 0 6 1 0 0 0 1
Lengt Lengt lengt L Le Len Leng BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
h h h h h h h BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 1 0 0 0 0 0 0 0 3 9 no 0 3 1 0 0 0 1
(Å) (Å) (å) ( (Å (Å) (Å) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 () 2 6 1 0 0 0 1
22 22 22 2 22 22 22 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 9 no 0 3 0 0 0 0 1
-10.1334 -10.1334 -10.1334 - -1 -10 -10. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 9 -. 2 10 0 0 0 0 1
Leu54 Leu54 leu54 L Le Leu Leu5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
Met50 Met50 met50 M Me Met Met5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
Lys51 Lys51 lys51 L Ly Lys Lys5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
Leu54 Leu54 leu54 L Le Leu Leu5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 no 0 10 1 0 0 0 1
C (piperazine) c C C C C BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 9 () 2 5 1 0 0 0 1
Benzimidazole ring benzimidazole B Be Ben Benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 no 0 6 1 0 0 0 1
Ph (1,2,4,5-tetrasubstituted) ph P Ph Ph Ph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 9 (,,,-) 6 10 1 0 0 0 1
1,3,5-triazine ring 1,3,5-triazine 1 1, 1,3 1,3, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 ,,- 3 6 1 0 0 0 1
H-donor H-donor h-donor H H- H-d H-do BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 10 - 1 10 1 0 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 - 1 5 1 0 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 - 1 5 1 0 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 10 - 1 5 1 0 0 0 1
3.65 3.65 3.65 3 3. 3.6 3.65 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 1 0 0 0 1
4.45 4.45 4.45 4 4. 4.4 4.45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 1 0 0 0 1
4.83 4.83 4.83 4 4. 4.8 4.83 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 1 0 0 0 1
4.06 4.06 4.06 4 4. 4.0 4.06 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 . 1 10 1 0 0 0 1
Figure 6. figure F Fi Fig Figu BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 .,-() 5 10 1 0 0 0 1
of MDM2. of o of of of BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 .:-,-,-,-. 10 9 1 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ....,, 6 10 0 1 1 0 1
10 of 10 1 10 10 10 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 0 no 0 10 0 1 0 0 1
Table 3. table T Ta Tab Tabl BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 .,(:). 6 10 0 1 0 0 1
Compound Compound compound C Co Com Comp BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 8 0 1 0 0 1
S S s S S S S BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 no 0 1 0 1 0 0 1
(kcal/mol) (kcal/mol) (kcal/mol) ( (k (kc (kca BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 (/) 3 10 0 1 0 0 1
Amino Amino amino A Am Ami Amin BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 3 0 1 0 0 1
Acids Acids acids A Ac Aci Acid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 3 0 1 0 0 1
Interacting Groups interacting I In Int Inte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 1 0 0 1
Type of type T Ty Typ Type BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 4 0 1 0 0 1
Interaction Interaction interaction I In Int Inte BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 3 0 no 0 6 0 1 0 0 1
Length Length length L Le Len Leng BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 no 0 10 0 1 0 0 1
(Å) (Å) (å) ( (Å (Å) (Å) BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 () 2 5 0 1 0 0 1
22 22 22 2 22 22 22 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 0 no 0 3 0 1 0 0 1
-10.1334 -10.1334 -10.1334 - -1 -10 -10. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 3 0 -. 2 10 0 1 0 0 1
Leu54 Leu54 leu54 L Le Leu Leu5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 2 0 1 0 0 1
C (piperazine) c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 0 () 2 5 0 1 0 0 1
H-donor H-donor h-donor H H- H-d H-do BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 2 0 1 0 0 1
3.65 3.65 3.65 3 3. 3.6 3.65 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 . 1 1 0 1 0 0 1
Met50 Met50 met50 M Me Met Met5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 2 0 1 0 0 1
Benzimidazole ring benzimidazole B Be Ben Benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 no 0 6 0 1 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 1 0 1 0 0 1
4.45 4.45 4.45 4 4. 4.4 4.45 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 . 1 1 0 1 0 0 1
Lys51 Lys51 lys51 L Ly Lys Lys5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 2 0 1 0 0 1
Ph (1,2,4,5-tetrasubstituted) ph P Ph Ph Ph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 (,,,-) 6 10 0 1 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 1 0 1 0 0 1
4.83 4.83 4.83 4 4. 4.8 4.83 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 . 1 1 0 1 0 0 1
Leu54 Leu54 leu54 L Le Leu Leu5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 2 0 1 0 0 1
1,3,5-triazine ring 1,3,5-triazine 1 1, 1,3 1,3, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ,,- 3 6 0 1 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 1 0 1 0 0 1
4.06 4.06 4.06 4 4. 4.0 4.06 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 . 1 1 0 1 0 0 1
Leu54 Leu54 leu54 L Le Leu Leu5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 no 0 2 0 1 0 0 1
1,3,5-triazine ring 1,3,5-triazine 1 1, 1,3 1,3, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 ,,- 3 6 0 1 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 - 1 1 0 1 0 0 1
3.61 3.61 3.61 3 3. 3.6 3.61 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 . 1 1 0 1 0 0 1
46 46 46 4 46 46 46 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 1 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 1 no 0 3 0 0 0 0 1
-9.7475 -9.7475 -9.7475 - -9 -9. -9.7 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 -. 2 10 0 0 0 0 1
Leu54 Leu54 leu54 L Le Leu Leu5 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 no 0 3 0 0 0 0 1
C (piperazine) c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 1 () 2 7 0 0 0 0 1
H-donor H-donor h-donor H H- H-d H-do BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 - 1 4 0 0 0 0 1
3.61 3.61 3.61 3 3. 3.6 3.61 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 . 1 2 0 0 0 0 1
Met62 Met62 met62 M Me Met Met6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 no 0 3 0 0 0 0 1
C (4-F-C c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 1 (--) 4 8 0 0 0 0 1
H-donor H-donor h-donor H H- H-d H-do BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 - 1 4 0 0 0 0 1
3.72 3.72 3.72 3 3. 3.7 3.72 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 . 1 2 0 0 0 0 1
Lys51 Lys51 lys51 L Ly Lys Lys5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 no 0 3 0 0 0 0 1
O (S=O o O O O O BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 1 () 2 10 0 0 0 0 1
H-acceptor H-acceptor h-acceptor H H- H-a H-ac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 - 1 5 0 0 0 0 1
3.34 3.34 3.34 3 3. 3.3 3.34 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 . 1 2 0 0 0 0 1
Leu54 Leu54 leu54 L Le Leu Leu5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 no 0 3 0 0 0 0 1
1,3,5-triazine ring 1,3,5-triazine 1 1, 1,3 1,3, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 ,,- 3 10 0 0 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 - 1 2 0 0 0 0 1
4.15 4.15 4.15 4 4. 4.1 4.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 . 1 2 0 0 0 0 1
Leu54 Leu54 leu54 L Le Leu Leu5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 no 0 3 0 0 0 0 1
1,3,5-triazine ring 1,3,5-triazine 1 1, 1,3 1,3, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 ,,- 3 10 0 0 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 - 1 2 0 0 0 0 1
3.57 3.57 3.57 3 3. 3.5 3.57 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 . 1 2 0 0 0 0 1
Tyr100 Tyr100 tyr100 T Ty Tyr Tyr1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 no 0 3 0 0 0 0 1
Benzimidazole ring benzimidazole B Be Ben Benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 1 no 0 9 0 0 0 0 1
π-π stacking π-π π π- π-π π-π BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 1 - 1 6 0 0 0 0 1
4.22 4.22 4.22 4 4. 4.2 4.22 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 1 . 1 2 0 0 0 0 1
Nutlin-3a Nutlin-3a nutlin-3a N Nu Nut Nutl BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 - 1 10 0 1 0 0 1
-10.8029 -10.8029 -10.8029 - -1 -10 -10. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 -. 2 9 0 1 0 0 1
Met62 Met62 met62 M Me Met Met6 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 no 0 2 0 1 0 0 1
C (piperazine) c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 3 () 2 5 0 1 0 0 1
H-donor H-donor h-donor H H- H-d H-do BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 - 1 3 0 1 0 0 1
3.95 3.95 3.95 3 3. 3.9 3.95 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 . 1 1 0 1 0 0 1
Met62 Met62 met62 M Me Met Met6 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 no 0 2 0 1 0 0 1
C (i-PrO) c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 3 (-) 3 3 0 1 0 0 1
H-donor H-donor h-donor H H- H-d H-do BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 - 1 3 0 1 0 0 1
3.82 3.82 3.82 3 3. 3.8 3.82 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 . 1 1 0 1 0 0 1
His96 His96 his96 H Hi His His9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 no 0 2 0 1 0 0 1
Cl (4-Cl-C cl C Cl Cl Cl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 (--) 4 7 0 1 0 0 1
H-donor H-donor h-donor H H- H-d H-do BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 - 1 3 0 1 0 0 1
3.84 3.84 3.84 3 3. 3.8 3.84 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 . 1 1 0 1 0 0 1
Gly58 Gly58 gly58 G Gl Gly Gly5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 no 0 2 0 1 0 0 1
O [=N-(C=O)-N=] o O O O O BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 3 [-()-] 6 6 0 1 0 0 1
H-acceptor H-acceptor h-acceptor H H- H-a H-ac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 - 1 4 0 1 0 0 1
3.29 3.29 3.29 3 3. 3.2 3.29 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 . 1 1 0 1 0 0 1
Gln59 Gln59 gln59 G Gl Gln Gln5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 no 0 2 0 1 0 0 1
O (piperazin-2-one) o O O O O BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 3 3 (--) 4 7 0 1 0 0 1
H-acceptor H-acceptor h-acceptor H H- H-a H-ac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 - 1 4 0 1 0 0 1
2.87 2.87 2.87 2 2. 2.8 2.87 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 . 1 1 0 1 0 0 1
Leu54 Leu54 leu54 L Le Leu Leu5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 no 0 2 0 1 0 0 1
Ph (4-Cl-C ph P Ph Ph Ph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 (--) 4 7 0 1 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 - 1 1 0 1 0 0 1
4.48 4.48 4.48 4 4. 4.4 4.48 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 . 1 1 0 1 0 0 1
Val93 Val93 val93 V Va Val Val9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 no 0 2 0 1 0 0 1
Ph (1,2,4-trisubstituted) ph P Ph Ph Ph BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 3 (,,-) 5 10 0 1 0 0 1
π-H π-H π-h π π- π-H π-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 3 - 1 1 0 1 0 0 1
3.75 3.75 3.75 3 3. 3.7 3.75 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 3 . 1 1 0 1 0 0 1
3. Materials 3. 3 3. 3. 3. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 . 1 10 0 1 0 0 1
3.1. General 3.1. 3 3. 3.1 3.1. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 4 .. 2 10 0 1 0 0 1
Melting points melting M Me Mel Melt BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 4 (, 2 9 0 1 0 0 1
UK) apparatus uk) U UK UK) UK) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 4 ). 2 9 0 1 0 0 1
(Thermo Fisher (thermo ( (T (Th (The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 4 (,,,);--. 9 10 0 1 0 0 1
1 H 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 3 4 (,, 3 9 0 1 0 0 1
CA, USA). ca, C CA CA, CA, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 ,).()., 7 9 0 0 0 0 1
is presented is i is is is BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 :(),(),(),(),(). 16 10 0 0 0 0 1
were obtained were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (, 2 8 0 0 0 0 1
Shelton, CT, shelton, S Sh She Shel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 ,,). 4 8 0 0 0 0 1
the theoretical the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 .-() 4 9 0 0 0 0 1
plates (Merck, plates p pl pla plat BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 (,,). 5 8 0 0 0 0 1
(HRMS) was (hrms) ( (H (HR (HRM BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 5 ()(,,,) 7 8 0 0 0 0 1
equipped with equipped e eq equ equi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 5 no 0 8 0 0 0 0 1
200 (Eksigent 200 2 20 200 200 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 5 (,,);:-(.,.) 12 8 0 0 0 0 1
(Eksigent), thermostated (eksigent), ( (E (Ek (Eks BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 5 (),•;:/;::.,: 13 9 0 0 0 0 1
0.1% formic 0.1% 0 0. 0.1 0.1% BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 .;,. 4 6 0 0 0 0 1
The following the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 5 : 1 7 0 0 0 0 1
3-amino-6-chloro-7-methyl-1,1-dioxo-1,4,2-benzodithiazine (1) 3-amino-6-chloro-7-methyl-1,1-dioxo-1,4,2-benzodithiazine 3 3- 3-a 3-am BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 ------,--,,-()-[---(- 21 8 0 0 0 0 1
cyanosulfamoyl)-4-methylphenylthio]acetate potassium cyanosulfamoyl)-4-methylphenylthio]acetate c cy cya cyan BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 5 )--]()[]. 9 6 0 0 0 0 1
3.2. Synthesis 3.2. 3 3. 3.2 3.2. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 9 .. 2 10 0 0 0 0 1
3.2.1. General 3.2.1. 3 3. 3.2 3.2. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 ...-[--[-(---[]-()- 19 10 0 0 0 0 1
ylidene)sulfamoyl]-4-methylphenyl]thio}acetate 3-5 ylidene)sulfamoyl]-4-methylphenyl]thio}acetate y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 10 )]--]- 6 5 0 0 0 0 1
To the to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 10 -[---(-)--] 11 9 0 0 0 0 1
salt (2) salt s sa sal salt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 ()(.,)()-,-(.) 14 10 0 0 0 0 1
was added. was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 .., 3 9 0 0 0 0 1
was filtered was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 ,(.). 5 9 0 0 0 0 1
purified by purified p pu pur puri BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 3 10 . 1 4 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ....,, 6 10 0 1 1 0 1
11 of 11 1 11 11 11 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 3 0 no 0 10 0 1 0 0 1
Ethyl 2-{2-[N-(1H-benzo[d]imidazol-2(3H)-ylidene)sulfamoyl]-5-chloro-4-methylphenylthio}acetate ethyl E Et Eth Ethy BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 3 0 --[-(-[]-()-)]----(). 21 10 0 1 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 3 0 -,-(.,.). 9 8 0 0 0 0 1
crystallization from crystallization c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 3 0 ..();..-•;():(-),, 18 9 0 0 0 0 1
(C-H), 1736 (c-h), ( (C (C- (C-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 (-),(),,,(,),,(),(-)-; 22 9 0 0 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 (,-):.-.(,.,,-),.(,,-),.(,, 27 9 0 0 0 0 1
S-CH 2 s-ch S S- S-C S-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 -),.-.(,.,,-),.-.(,,),.(,,-),.(,, 33 10 0 0 0 0 1
H-6), 11.96 h-6), H H- H-6 H-6) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 3 0 -),.(,,,);..(.);,.; 19 9 0 0 0 0 1
H, 4.12; h, H H, H, H, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 3 0 ,.;,..:,.;,.;,.. 16 4 0 0 0 0 1
Ethyl 2-{5-fluoro-2-[N-(5-chloro-1H-benzo[d]imidazol-2(3H)-ylidene)sulfamoyl]-4-methylphenylthio} ethyl E Et Eth Ethy BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 4 2 ----[-(---[]-()-)]--(). 23 10 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 --,-(.,.). 10 8 0 0 0 0 1
Yield 0.414 yield Y Yi Yie Yiel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 .();..-•;():(-),,,,(-),(), 26 9 0 0 0 0 1
1633, 1534, 1633, 1 16 163 1633 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 2 ,,(,),,()-;(,-):.-.(, 21 9 0 0 0 0 1
J=7.35 Hz, j=7.35 J J= J=7 J=7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 .,,),.(,,),.(,,-),.-.(,,),.-. 29 10 0 0 0 0 1
(m, 3H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 (,,),.(,,-),.(,,-),.(,,,);. 27 9 0 0 0 0 1
calcd. for calcd. c ca cal calc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 .(.);,.;,.;,..:,.;,.;,.. 24 9 0 0 0 0 1
Ethyl 2-{5-chloro-2-[N-(5-chloro-1H-benzo[d]imidazol-2(3H)-ylidene)sulfamoyl]-4-methylphenyl-thio}acetate ethyl E Et Eth Ethy BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 1 0 0 0 0 0 0 4 4 ----[-(---[]-()-)]---(). 24 10 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 --,-(.,.). 10 8 0 0 0 0 1
Yield 0.428 yield Y Yi Yie Yiel BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 .();..-•(.);():(-),,,(-),(), 28 9 0 0 0 0 1
1626, 1468 1626, 1 16 162 1626 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 5 ,(,),,(),-;(,-):.-.(, 21 9 0 0 0 0 1
J=7.1 Hz, j=7.1 J J= J=7 J=7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,,),.(,,),.(,,-),.-.(,.,,), 28 10 0 0 0 0 1
7.15-7.30 (m, 7.15-7.30 7 7. 7.1 7.15 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .-.(,,),.(,,-),.(,,-),.(,,,) 28 9 0 0 0 0 1
ppm; Anal.calcd. ppm; p pp ppm ppm; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 5 ;..(.);,.;,.;,..:,.;,.; 23 10 0 0 0 0 1
N, 8.85. n, N N, N, N, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 5 ,.. 3 0 0 0 0 0 1
3.2.2. General 3.2.2. 3 3. 3.2 3.2. BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 ...--[(--,,--- 14 9 0 0 0 0 1
yl)methylthio]-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide 6-32 yl)methylthio]-n-(1h-benzo[d]imidazol-2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yl) yl)m BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 )]--(-[]-()-)----- 18 10 0 0 0 0 1
To the to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 7 (., 3 6 0 0 0 0 1
1.60 mmol) 1.60 1 1. 1.6 1.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 .)(.),-[-[-(-[]-()- 19 8 0 0 0 0 1
ylidene)sulfamoyl]-5-chloro-4-methylphenyl}thio]acetate (3) ylidene)sulfamoyl]-5-chloro-4-methylphenyl}thio]acetate y yl yli ylid BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 7 )]----]()(.,.) 14 9 0 0 0 0 1
appropriate biguanide appropriate a ap app appr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (.). 4 9 0 0 0 0 1
reflux for reflux r re ref refl BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 7 ., 2 10 0 0 0 0 1
water (25 water w wa wat wate BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 (). 3 9 0 0 0 0 1
solvent or solvent s so sol solv BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 7 ,. 2 9 0 0 0 0 1
2-{[4-Amino-6-(dimethylamino)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4- 2-{[4-Amino-6-(dimethylamino)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4- 2-{[4-amino-6-(dimethylamino)-1,3,5-triazin-2-yl]methylthio}-n-(1h-benzo[d]imidazol-2(3h)-ylidene)-4- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 -[---()-,,---]--(-[]-()-)-- 27 10 0 0 0 0 1
chloro-5-methylbenzenesulfonamide (6). chloro-5-methylbenzenesulfonamide c ch chl chlo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 8 --(). 5 3 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 9 ,-(.,.). 8 8 0 0 0 0 1
obtained after obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 4 9 (:)..();..- 11 9 0 0 0 0 1
• C; • • • • • BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 9 •;():,,(-),,,(-),,(),,()-; 26 10 0 0 0 0 1
1 H 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 4 9 (,-):.(,,),.(.,,),.(,,-),.-. 28 10 0 0 0 0 1
(m, 4H, (m, ( (m (m, (m, BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 (,,,),.(,,-),.(,,-),.(,,,) 26 9 0 0 0 0 1
ppm; 13 ppm; p pp ppm ppm; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 10 ;(-):.,.,.,.,.,.,.,.,.,., 25 9 0 0 0 0 1
136.91, 136.98, 136.91, 1 13 136 136. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 .,.,.,.,.,.,.;..(.);, 21 10 0 0 0 0 1
47.57; H, 47.57; 4 47 47. 47.5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 10 .;,.;,..:,.;,.;,.. 18 5 0 0 0 0 1
2-[(4-Amino-6-morpholino-1,3,5-triazin-2-yl)methylthio]-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4-chloro-5- 2-[(4-Amino-6-morpholino-1,3,5-triazin-2-yl)methylthio]-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4-chloro-5- 2-[(4-amino-6-morpholino-1,3,5-triazin-2-yl)methylthio]-n-(1h-benzo[d]imidazol-2(3h)-ylidene)-4-chloro-5- 2 2- 2-[ 2-[( BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 11 -[(----,,---)]--(-[]-()-)---- 29 10 0 0 0 0 1
methylbenzenesulfonamide (7). methylbenzenesulfonamide m me met meth BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 11 (). 3 2 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ....,, 6 10 0 1 1 0 1
12 of 12 1 12 12 12 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 4 0 no 0 10 0 1 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 ---(., 6 7 0 1 0 0 1
1.60 mmol). 1.60 1 1. 1.6 1.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .). 3 1 0 1 0 0 1
The title the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 no 0 6 0 1 0 0 1
dimethylformamide/water (7:3). dimethylformamide/water d di dim dime BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 0 /(:)..();..-•(.);():, 21 8 0 1 0 0 1
3326, 3235 3326, 3 33 332 3326 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 ,(-),,,(-),,(,),,()-; 21 9 0 1 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 (,-):.(,,),.(,,),.-.(,,), 25 9 0 1 0 0 1
3.87 (s, 3.87 3 3. 3.8 3.87 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 0 .(,,-),.(,,,),.(,,-),.(,,-),.(,, 32 10 0 1 0 0 1
NH, benzimidazolidine) nh, N NH NH, NH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 0 ,);..(.);,.;,.;,.. 18 9 0 1 0 0 1
Found: C, found: F Fo Fou Foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 0 :,.;,.;,..(-).[] 16 9 0 1 0 0 1
547.1101 found 547.1101 5 54 547 547. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 4 0 ... 3 2 0 1 0 0 1
2-{[4-Amino-6-(3,5,5-trimethyl-4,5-dihydro-1H-pyrazol-1-yl)-1,3,5-triazin-2-yl]metylthio}-N-(1H- 2-{[4-Amino-6-(3,5,5-trimethyl-4,5-dihydro-1H-pyrazol-1-yl)-1,3,5-triazin-2-yl]metylthio}-N-(1H- 2-{[4-amino-6-(3,5,5-trimethyl-4,5-dihydro-1h-pyrazol-1-yl)-1,3,5-triazin-2-yl]metylthio}-n-(1h- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 -[---(,,--,-----)-,,---]--(- 28 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (8). benzo[d]imidazol-2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 []-()-)----(). 14 7 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 2 --,,--,----- 12 8 0 0 0 0 1
hydrochloride (0.372 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 4 2 (.,.). 6 9 0 0 0 0 1
(1:3), and (1:3), ( (1 (1: (1:3 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 (:),(:)..();..-•(.);():, 24 10 0 0 0 0 1
3319, 3267 3319, 3 33 331 3319 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 ,(-),,,(-),,(,),,()-; 21 9 0 0 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 (,-):.-.(,,,),.(..,,,),.(, 26 9 0 0 0 0 1
3H, CH 3h, 3 3H 3H, 3H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 2 ,),.(,,,),.-.(,,-),.-.(,,, 26 9 0 0 0 0 1
H Ar h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 2 ,-),.(,,-),.(,,,);.. 20 9 0 0 0 0 1
C 24 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 4 2 (.);,.;,.;,..:,.;,.;,.. 23 9 0 0 0 0 1
(ESI-TOF) 571.1339 (esi-tof) ( (E (ES (ESI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 4 2 (-).[]... 9 8 0 0 0 0 1
2-{[4-Amino-6-(indolin-1-yl)-1,3,5-triazin-2-yl]metylthio}-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4- 2-{[4-Amino-6-(indolin-1-yl)-1,3,5-triazin-2-yl]metylthio}-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4- 2-{[4-amino-6-(indolin-1-yl)-1,3,5-triazin-2-yl]metylthio}-n-(1h-benzo[d]imidazol-2(3h)-ylidene)-4- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 -[---(--)-,,---]--(-[]-()-)-- 29 10 0 0 0 0 1
chloro-5-methylbenzenesulfonamide (9). chloro-5-methylbenzenesulfonamide c ch chl chlo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 --(). 5 3 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 ---(.,.). 9 8 0 0 0 0 1
The title the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 4 5 (:)..();.. 10 9 0 0 0 0 1
273-274 • 273-274 2 27 273 273- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 -•(.);():,,(-),,(-),,(,),, 26 9 0 0 0 0 1
1140 (SO 1140 1 11 114 1140 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 4 5 ()-;(,-):.(,,),.-.(,.,, 23 9 0 0 0 0 1
3H-indolinyl), 3.94 3h-indolinyl), 3 3H 3H- 3H-i BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 -),.(,,),.(,,-),.-.(,,,),.(, 28 10 0 0 0 0 1
1H, H-3), 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 ,-),.(,,-),.(,,,);(-):., 24 9 0 0 0 0 1
26.44, 39.37, 26.44, 2 26 26. 26.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,.,.,.,.,.,.,.,.,.,.,.,.,., 28 9 0 0 0 0 1
132.58, 135.22, 132.58, 1 13 132 132. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 .,.,.,.,.,.,.,.;.. 18 9 0 0 0 0 1
(579.10); C, (579.10); ( (5 (57 (579 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 4 5 (.);,.;,.;,..:,.;,.;,.. 23 6 0 0 0 0 1
2-{[4-Amino-6-(3,4-dihydroquinolin-1(2H)-yl)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)- 2-{[4-Amino-6-(3,4-dihydroquinolin-1(2H)-yl)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)- 2-{[4-amino-6-(3,4-dihydroquinolin-1(2h)-yl)-1,3,5-triazin-2-yl]methylthio}-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 -[---(,--()-)-,,---]--(-[]-()- 30 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (10). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 )----(). 8 4 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 --,--()- 8 7 0 0 0 0 1
(0.406 g, (0.406 ( (0 (0. (0.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 (.,.). 6 8 0 0 0 0 1
ethanol (1:28). ethanol e et eth etha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 (:)..();..-•;():,,(-),,, 24 8 0 0 0 0 1
2891, 2866 2891, 2 28 289 2891 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 8 ,(-),,(,),,()-;(,-): 20 8 0 0 0 0 1
1.77-1.82 (pent, 1.77-1.82 1 1. 1.7 1.77 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 .-.(,.;,-,),.(,,),.(,.;,-, 26 9 0 0 0 0 1
dihydroquinoline), 3.85 dihydroquinoline), d di dih dihy BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 8 ),.(,.,,-),.(,,-),.-.(,, 24 9 0 0 0 0 1
H Ar h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 5 8 ,),.(,,-),.(,,-),.(,,,); 24 8 0 0 0 0 1
Anal. calcd. anal. A An Ana Anal BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 8 ..(.);,.;,.;,..:,.;,.;,.. 25 10 0 0 0 0 1
2-{[4-Amino-6-(phenylamino)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4- 2-{[4-Amino-6-(phenylamino)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4- 2-{[4-amino-6-(phenylamino)-1,3,5-triazin-2-yl]methylthio}-n-(1h-benzo[d]imidazol-2(3h)-ylidene)-4- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 -[---()-,,---]--(-[]-()-)-- 27 10 0 0 0 0 1
chloro-5-methylbenzenesulfonamide (11). chloro-5-methylbenzenesulfonamide c ch chl chlo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 10 --(). 5 4 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 11 -(.,.). 7 8 0 0 0 0 1
obtained after obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 11 ()..();..-• 11 9 0 0 0 0 1
(dec.); IR (dec.); ( (d (de (dec BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 11 (.);():,(-),,(-.),,(,),,()-; 28 10 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ....,, 6 10 0 1 1 0 1
13 of 13 1 13 13 13 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 0 1 0 0 1
1 H 1 1 1 1 1 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 0 (,-):.(,,),.(,,-),.-.(,,, 25 10 0 1 0 0 1
H-3 and h-3 H H- H-3 H-3 BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -,),.(,,-),.(,,),.(,,,); 24 8 0 0 0 0 1
Anal. calcd. anal. A An Ana Anal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 ..(.);,.;,.;,..:,.;,.;,.. 25 10 0 0 0 0 1
HRMS (ESI-TOF) hrms H HR HRM HRMS BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 (-).[]... 9 8 0 0 0 0 1
2-[{4-Amino-6-[(4-fluorophenyl)amino]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-Amino-6-[(4-fluorophenyl)amino]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-amino-6-[(4-fluorophenyl)amino]-1,3,5-triazin-2-yl}metylthio]-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 -[---[(-)]-,,---]--(-[]-()- 27 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (12). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 )----(). 8 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 1 -(-)(.,.). 10 8 0 0 0 0 1
was obtained. was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 ..();..-•(.);():,(-),, 22 9 0 0 0 0 1
(C-H), 1604, (c-h), ( (C (C- (C-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 (-),,,,(,),,()-;(,-): 21 9 0 0 0 0 1
2.31 (m, 2.31 2 2. 2.3 2.31 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 .(,,),.(,,-),.-.(,,,,-),.(, 27 9 0 0 0 0 1
1H, H-6), 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 1 ,-),.(,,,---),.(,,,);.. 23 9 0 0 0 0 1
for C for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 1 (.);,.;,.;,..:,.;,.;,,. 23 10 0 0 0 0 1
(ESI-TOF) (570.0823) (esi-tof) ( (E (ES (ESI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 1 (-)(.)[](.).. 13 8 0 0 0 0 1
2-[{4-Amino-6-[(4-chlorophenyl)amino]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-Amino-6-[(4-chlorophenyl)amino]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-amino-6-[(4-chlorophenyl)amino]-1,3,5-triazin-2-yl}metylthio]-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 -[---[(-)]-,,---]--(-[]-()- 27 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (13). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 3 )----(). 8 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 4 -(-)(.,.). 10 8 0 0 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 (.), 4 9 0 0 0 0 1
with water with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 (),,..();..-•;():, 18 8 0 0 0 0 1
3180 (N-H), 3180 3 31 318 3180 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 4 (-),,,,(-),,(,),,()-; 21 9 0 0 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 4 (,-):.(,,),.(,,-),.-.(,,, 25 9 0 0 0 0 1
and 1H, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 4 ,-),.(,,-),.(,,---),.(,,,) 26 9 0 0 0 0 1
ppm; Anal. ppm; p pp ppm ppm; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 4 ;..(.);,.;,.;,..:,.;,.; 23 10 0 0 0 0 1
N, 19.08. n, N N, N, N, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 4 ,..(-)(.)[](.).. 16 9 0 0 0 0 1
2-[{4-Amino-6-[(4-methoxyphenyl)amino]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-Amino-6-[(4-methoxyphenyl)amino]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-amino-6-[(4-methoxyphenyl)amino]-1,3,5-triazin-2-yl}metylthio]-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 -[---[(-)]-,,---]--(-[]-()- 27 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (14). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 6 )----(). 8 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 6 -(-)(.,.). 10 8 0 0 0 0 1
compound was compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (:) 3 8 0 0 0 0 1
precipitate was precipitate p pr pre prec BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 6 (.)..();..-•(.); 16 9 0 0 0 0 1
(KBr): 3350, (kbr): ( (K (KB (KBr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 6 ():,,(-),,,(-),,(,),,()-; 25 10 0 0 0 0 1
1 H 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 5 6 (,-):.(,,),.(,,---),.(,, 24 9 0 0 0 0 1
S-CH 2 s-ch S S- S-C S-CH BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 8 -),.-.(,,,,-),.(,,-),.(,,, 26 9 0 0 0 0 1
4-MeO-C 6 4-meo-c 4 4- 4-M 4-Me BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 ---),.(,,,);.. 14 10 0 0 0 0 1
(583.08); C, (583.08); ( (5 (58 (583 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 8 (.);,.;,.;,..:,,;,.;,.. 23 7 0 0 0 0 1
2-{[4-Amino-6-(benzylamino)-1,3,5-triazin-2-yl]metylthio}-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4- 2-{[4-Amino-6-(benzylamino)-1,3,5-triazin-2-yl]metylthio}-N-(1H-benzo[d]imidazol-2(3H)-ylidene)-4- 2-{[4-amino-6-(benzylamino)-1,3,5-triazin-2-yl]metylthio}-n-(1h-benzo[d]imidazol-2(3h)-ylidene)-4- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 -[---()-,,---]--(-[]-()-)-- 27 10 0 0 0 0 1
chloro-5-methylbenzenesulfonamide (15). chloro-5-methylbenzenesulfonamide c ch chl chlo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 --(). 5 4 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 9 -(.,.). 7 8 0 0 0 0 1
mixture was mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 ()()., 6 9 0 0 0 0 1
then mixed then t th the then BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 (),,..();...-.•;(): 19 9 0 0 0 0 1
3388, 3299, 3388, 3 33 338 3388 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 ,,(-),(-),,,(-),,(,),, 22 9 0 0 0 0 1
(SO 2 (so ( (S (SO (SO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 ()-;(,-,•):.(,,),.(,,-),.(, 27 10 0 0 0 0 1
2H, CH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 9 ,-),.-.(,,,),.(,,-),.(,,-),.(,, 31 9 0 0 0 0 1
NH benzimidazole)ppm; nh N NH NH NH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 );..(.);,.;,.;,..: 18 9 0 0 0 0 1
C, 52.89; c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 9 ,.;,.;,..(-)(.)[](.) 20 9 0 0 0 0 1
found 567.1146. found f fo fou foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 9 .. 2 1 0 0 0 0 1
2-[{4-Amino-6-[methyl(phenyl)amino]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)-ylidene)- 2-[{4-Amino-6-[methyl(phenyl)amino]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)-ylidene)- 2-[{4-amino-6-[methyl(phenyl)amino]-1,3,5-triazin-2-yl}metylthio]-n-(1h-benzo[d]imidazol-2(3h)-ylidene)- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 11 -[---[()]-,,---]--(-[]-()-)- 28 10 0 0 0 0 1
4-chloro-5-methylbenzenesulfonamide (16). 4-chloro-5-methylbenzenesulfonamide 4 4- 4-c 4-ch BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 11 ---(). 6 4 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ....,, 6 10 0 1 1 0 1
14 of 14 1 14 14 14 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 5 0 no 0 10 0 1 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 0 ---(.,.). 9 8 0 1 0 0 1
was obtained was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 0 /(:)..();.. 11 9 0 1 0 0 1
231-232 • 231-232 2 23 231 231- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 -•;():,,(-),,(-),,(,),, 23 9 0 1 0 0 1
(SO 2 (so ( (S (SO (SO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 0 ()-;(,-):.(,,),.(,,-),.-.(, 27 9 0 1 0 0 1
10H, H 10h, 1 10 10H 10H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ,,),.(,,-),.(,,-),.(,,,) 24 8 0 1 0 0 1
ppm; Anal. ppm; p pp ppm ppm; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 0 ;..(.);,.;,.;,..:,.;,.;, 24 10 0 1 0 0 1
19.11. HRMS 19.11. 1 19 19. 19.1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 0 ..(-).[]... 11 8 0 1 0 0 1
2-[{4-Amino-6-[(4-chlorophenyl)(methyl)amino]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-Amino-6-[(4-chlorophenyl)(methyl)amino]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-amino-6-[(4-chlorophenyl)(methyl)amino]-1,3,5-triazin-2-yl}methylthio]-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 -[---[(-)()]-,,---]--(-[]-()- 29 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (17). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 )----(). 8 4 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 -(-)--(.,.). 12 8 0 0 0 0 1
compound was compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 5 2 (:).(); 7 9 0 0 0 0 1
m.p. 248-249 m.p. m m. m.p m.p. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 5 2 ..-•;():,(-),,,,(-),,,(,), 26 9 0 0 0 0 1
1290, 1140 1290, 1 12 129 1290 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 5 2 ,()-;(,-):.(,,),.(,,-),.(, 26 10 0 0 0 0 1
2H, S-CH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 ,-),.-.(,,,),.(,,-),.(,,-),.(,, 31 9 0 0 0 0 1
NH, benzimidazolidine) nh, N NH NH, NH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 5 2 ,);..(.);,.;,.;,.. 18 9 0 0 0 0 1
Found: C, found: F Fo Fou Foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 5 2 :,.;,.;,..(-).[] 16 9 0 0 0 0 1
505.0995 found 505.0995 5 50 505 505. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 5 2 ... 3 2 0 0 0 0 1
2-{[4-Amino-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-yl]metylthio}-N-(1H-benzo[d]imidazol-2(3H)- 2-{[4-Amino-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-yl]metylthio}-N-(1H-benzo[d]imidazol-2(3H)- 2-{[4-amino-6-(4-methylpiperazin-1-yl)-1,3,5-triazin-2-yl]metylthio}-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 -[---(---)-,,---]--(-[]-()- 27 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (18). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 )----(). 8 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 -----(. 7 8 0 0 0 0 1
g, 1.60 g, g g, g, g, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 ,.).(.) 7 8 0 0 0 0 1
solid was solid s so sol soli BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 ,(),..();.. 11 9 0 0 0 0 1
267-268 • 267-268 2 26 267 267- BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 -•.():,(),(-),,(-),,(,),, 25 9 0 0 0 0 1
1141 (SO 1141 1 11 114 1141 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 6 4 ()-;(,-):.(,,),.-.(,,), 23 9 0 0 0 0 1
2.32 (s, 2.32 2 2. 2.3 2.32 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 4 .(,,),.-.(,,),.(,,-),.-.(,,, 28 10 0 0 0 0 1
NH 2 nh N NH NH NH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 ),.(,,-),.(,,-),.(,,,);.. 25 9 0 0 0 0 1
for C for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 (.);,.;,.;,..:,.;,.;,.. 23 10 0 0 0 0 1
(ESI-TOF) (559.1339) (esi-tof) ( (E (ES (ESI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 (-)(.).[](.).. 14 8 0 0 0 0 1
2-{[4-Amino-6-(4-phenylpiperazin-1-yl)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)- 2-{[4-Amino-6-(4-phenylpiperazin-1-yl)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)- 2-{[4-amino-6-(4-phenylpiperazin-1-yl)-1,3,5-triazin-2-yl]methylthio}-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 -[---(---)-,,---]--(-[]-()- 27 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (19). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 )----(). 8 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 7 -----(., 8 8 0 0 0 0 1
1.60 mmol). 1.60 1 1. 1.6 1.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 .). 3 8 0 0 0 0 1
(1:11), a (1:11), ( (1 (1: (1:1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 7 (:),..();..-•(.); 17 10 0 0 0 0 1
IR (KBr): ir I IR IR IR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 7 ():,(-),,,(-),,(,),,()-; 24 9 0 0 0 0 1
1 H 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 6 7 (,-):.(,,),.-.(,,),.-.(,, 25 9 0 0 0 0 1
piperazine), 3.88 piperazine), p pi pip pipe BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 8 ),.(,,-),.-.(,,,),.(,,-),.(,, 29 9 0 0 0 0 1
H-6), 11.83 h-6), H H- H-6 H-6) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 -),.(,,,);(-):.,.,.,., 22 9 0 0 0 0 1
116.38, 119.76, 116.38, 1 11 116 116. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .,.,.,.,.,.,.,.,.,.,.,.,.,., 28 10 0 0 0 0 1
167.36, 174.40 167.36, 1 16 167 167. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .,.;..(.);,.;,.;,..:, 21 9 0 0 0 0 1
53.97; H, 53.97; 5 53 53. 53.9 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 8 .;,.;,..(-).[]. 15 9 0 0 0 0 1
622.1560. 622.1560. 622.1560. 6 62 622 622. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 8 .. 2 0 0 0 0 0 1
2-[{4-Amino-6-[4-(4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol- 2-[{4-Amino-6-[4-(4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol- 2-[{4-amino-6-[4-(4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-n-(1h-benzo[d]imidazol- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 -[---[-(-)--]-,,---]--(-[]- 27 10 0 0 0 0 1
2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (20). 2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide 2 2( 2(3 2(3H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 ()-)----(). 11 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 10 ---(-)-- 8 8 0 0 0 0 1
(0.481 g, (0.481 ( (0 (0. (0.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 (.,.).(:). 10 9 0 0 0 0 1
0.145 g 0.145 0 0. 0.1 0.14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 10 .();..-•(.);():,(),,(-.),,(, 28 10 0 0 0 0 1
C = c C C C C BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 10 ),,()-;(,-):.(,,),.(,, 22 9 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 ....,, 6 10 0 1 1 0 1
15 of 15 1 15 15 15 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 6 0 no 0 10 0 1 0 0 1
piperazine), 3.77-3.79 piperazine), p pi pip pipe BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 0 ),.-.(,,),.(,,-),.-.(,,,), 26 10 0 1 0 0 1
7.91 (m, 7.91 7 7. 7.9 7.91 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 0 .(,,-),.(,,-),.(,,,);.. 23 9 0 1 0 0 1
C 28 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 6 0 (.);,.;,.;,..:,.;,.;,.. 23 9 0 1 0 0 1
(ESI-TOF) 639.1402 (esi-tof) ( (E (ES (ESI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 0 (-).[]... 9 8 0 1 0 0 1
2-[{4-Amino-6-[4-(2-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-Amino-6-[4-(2-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-amino-6-[4-(2-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 -[---[-(-)--]-,,---]--(-[]-()- 30 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (21). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 )----(). 8 4 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 1 ---(-)-- 8 8 0 0 0 0 1
(0.481 g, (0.481 ( (0 (0. (0.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 (.,.). 6 9 0 0 0 0 1
ethanol (1:20). ethanol e et eth etha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 (:)..();..-•(.);():,,(-), 25 9 0 0 0 0 1
2944, 2888, 2944, 2 29 294 2944 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 1 ,,,(-),,,,(,),,()-; 19 9 0 0 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 (,-):.(,,),.-.(,,),.-.(,,), 27 9 0 0 0 0 1
3.89 (m, 3.89 3 3. 3.8 3.89 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 .(,,-),.-.(,,,),.(,,-),.(,,-),. 31 9 0 0 0 0 1
(m, 2H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 1 (,,,);..(.);,.;,.;, 19 10 0 0 0 0 1
19.69. Found: 19.69. 1 19 19. 19.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 1 ..:,.;,.;,.. 12 3 0 0 0 0 1
2-{[4-Amino-6-{4-[4-(trifluoromethyl)phenyl]piperazin-1-yl}-1,3,5-triazin-2-yl]methylthio}-N-(1H- 2-{[4-Amino-6-{4-[4-(trifluoromethyl)phenyl]piperazin-1-yl}-1,3,5-triazin-2-yl]methylthio}-N-(1H- 2-{[4-amino-6-{4-[4-(trifluoromethyl)phenyl]piperazin-1-yl}-1,3,5-triazin-2-yl]methylthio}-n-(1h- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 -[----[-()]---,,---]--(- 24 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (22). benzo[d]imidazol-2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 3 []-()-)----(). 14 7 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 ---[-()]-- 10 8 0 0 0 0 1
hydrochloride (0.561 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 (.;.). 6 9 0 0 0 0 1
with boiling with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 4 (:)..();...-.•(.);():,, 23 9 0 0 0 0 1
(N-H), 2924, (n-h), ( (N (N- (N-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 (-),,,(-),,(,),,()-;(, 22 9 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 -):.(,,),.(,,),.-.(,,),.(,, 27 9 0 0 0 0 1
S-CH 2 s-ch S S- S-C S-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 4 -),.-.(,,,),.(,,-),.(,,-),.(,,, 31 9 0 0 0 0 1
benzimidazolidine) ppm; benzimidazolidine) b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 4 );..(.);,.;,.;,.. 17 10 0 0 0 0 1
Found: C, found: F Fo Fou Foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 4 :,.;,.;,..(-).[] 16 9 0 0 0 0 1
690.1448 found 690.1448 6 69 690 690. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 6 4 ... 3 2 0 0 0 0 1
2-[{4-Amino-6-[4-(4-chlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol- 2-[{4-Amino-6-[4-(4-chlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol- 2-[{4-amino-6-[4-(4-chlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-n-(1h-benzo[d]imidazol- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 -[---[-(-)--]-,,---]--(-[]- 27 10 0 0 0 0 1
2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (23). 2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide 2 2( 2(3 2(3H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ()-)----(). 11 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 6 6 ---(-)-- 8 8 0 0 0 0 1
(0.508 g, (0.508 ( (0 (0. (0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 (.,.).(:), 10 9 0 0 0 0 1
next to next n ne nex next BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (), 3 9 0 0 0 0 1
the impurities the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 (:)..();..-•;():, 17 9 0 0 0 0 1
3370, 3228 3370, 3 33 337 3370 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 ,(-),,,,(-),(,),,()-; 21 9 0 0 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 6 6 (,-):.(,,),.-.(,,),.-.(,,- 26 9 0 0 0 0 1
and 4H, and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 6 6 ,),.-.(,,,),.(,,-),.(,,-),. 27 9 0 0 0 0 1
(m, 1H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 6 6 (,,,);..(.);,.;,.; 18 10 0 0 0 0 1
N, 19.20. n, N N, N, N, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 ,..:,.;,.;,..(-). 17 9 0 0 0 0 1
[M+H] + [m+h] [ [M [M+ [M+H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 6 6 []... 5 3 0 0 0 0 1
2-[{4-Amino-6-[4-(3-chlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol- 2-[{4-Amino-6-[4-(3-chlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol- 2-[{4-amino-6-[4-(3-chlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-n-(1h-benzo[d]imidazol- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 -[---[-(-)--]-,,---]--(-[]- 27 10 0 0 0 0 1
2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (24). 2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide 2 2( 2(3 2(3H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ()-)----(). 11 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 ---(-)-- 8 8 0 0 0 0 1
(0.508 g, (0.508 ( (0 (0. (0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 (.,.). 6 9 0 0 0 0 1
ethanol (1:31) ethanol e et eth etha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 (:)()..();.. 12 9 0 0 0 0 1
239.5-240.4 • 239.5-240.4 2 23 239 239. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .-.•.():,(-),,,,(-),,,, 23 9 0 0 0 0 1
(C=N, C=C (c=n, ( (C (C= (C=N BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 (,),,()-;(,-):.(,,),.(, 23 10 0 0 0 0 1
4H, piperazine), 4h, 4 4H 4H, 4H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ,),.(,,),.(,,-),.-.(,,,), 25 10 0 0 0 0 1
7.87 (m, 7.87 7 7. 7.8 7.87 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(,,-),.(,,-),.(,,,);.. 23 9 0 0 0 0 1
C 28 c C C C C BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 (.),.;,.;,..:,.;,.;,.. 22 9 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ....,, 6 10 0 1 1 0 1
16 of 16 1 16 16 16 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 1 0 0 1
2-[{4-Amino-6-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol- 2-[{4-Amino-6-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol- 2-[{4-amino-6-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-n-(1h-benzo[d]imidazol- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT HIGHERFONT 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 -[---[-(,-)--]-,,---]--(-[]- 28 10 0 1 0 0 1
2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (25). 2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide 2 2( 2(3 2(3H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ()-)----(). 11 5 0 1 0 0 1
Starting Starting starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 0 0 0 0 0 1
from from from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 no 0 0 0 0 0 0 1
N-carbamimidoyl-4-(3,4-dichlorophenyl)piperazine-1-carboximidamide N-carbamimidoyl-4-(3,4-dichlorophenyl)piperazine-1-carboximidamide n-carbamimidoyl-4-(3,4-dichlorophenyl)piperazine-1-carboximidamide N N- N-c N-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 ---(,-)-- 9 6 0 0 0 0 1
hydrochloride (0.563 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (.,.). 6 8 0 0 0 0 1
impurities with impurities i im imp impu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 0 (:). 4 9 0 0 0 0 1
0.149 g 0.149 0 0. 0.1 0.14 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .();..-•;():,,(-),,(-),,(, 26 9 0 0 0 0 1
C=C Ar c=c C C= C=C C=C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ),,()-;(,-):.(,,),.(,, 22 9 0 0 0 0 1
piperazine), 3.72-3.77 piperazine), p pi pip pipe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 ),.-.(,,),.(,,-),.-.(,,,), 26 9 0 0 0 0 1
7.92 (m, 7.92 7 7. 7.9 7.92 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 .(,,-),.(,,-),.(,,,);.. 23 9 0 0 0 0 1
C 28 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 0 (.);,.;,.;,..:,.;,.;,.. 23 10 0 0 0 0 1
(ESI-TOF) (689.0716) (esi-tof) ( (E (ES (ESI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 (-)(.)[](.).. 13 8 0 0 0 0 1
2-[{4-Amino-6-[4-(3-chloro-4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H- 2-[{4-Amino-6-[4-(3-chloro-4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H- 2-[{4-amino-6-[4-(3-chloro-4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-n-(1h- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 2 -[---[-(---)--]-,,---]--(- 26 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (26). benzo[d]imidazol-2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 2 []-()-)----(). 14 7 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 3 ---(---)-- 10 8 0 0 0 0 1
hydrochloride (0.536 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 (.,.). 6 9 0 0 0 0 1
with boiling with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 3 (:)..(); 8 9 0 0 0 0 1
m.p. 246.4-247.1 m.p. m m. m.p m.p. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 3 ...-.•;():,,(-),,,,(-),,,, 26 9 0 0 0 0 1
1462 (C=N, 1462 1 14 146 1462 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 7 3 (,),,();(,-):.(,,),.(, 22 10 0 0 0 0 1
4H, piperazine), 4h, 4 4H 4H, 4H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 ,),.(,,),.(,,-),.-.(,,,), 25 10 0 0 0 0 1
7.88 (m, 7.88 7 7. 7.8 7.88 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 3 .(,,-),.(,,-),.-.(,,,).. 24 9 0 0 0 0 1
C 28 c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 3 (.),.;,.;,..:,.;,.;,.. 22 9 0 0 0 0 1
2-[{4-Amino-6-[4-(4-methoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol- 2-[{4-Amino-6-[4-(4-methoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol- 2-[{4-amino-6-[4-(4-methoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-n-(1h-benzo[d]imidazol- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 -[---[-(-)--]-,,---]--(-[]- 27 10 0 0 0 0 1
2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (27). 2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide 2 2( 2(3 2(3H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ()-)----(). 11 5 0 0 0 0 1
Starting Starting starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 0 0 0 0 0 1
from from from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 no 0 0 0 0 0 0 1
N-carbamimidoyl-4-(2-methoxyphenyl)piperazine-1-carboximidamide N-carbamimidoyl-4-(2-methoxyphenyl)piperazine-1-carboximidamide n-carbamimidoyl-4-(2-methoxyphenyl)piperazine-1-carboximidamide N N- N-c N-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 5 ---(-)-- 8 5 0 0 0 0 1
hydrochloride (0.500 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (.,.). 6 8 0 0 0 0 1
impurities with impurities i im imp impu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 (:),. 5 9 0 0 0 0 1
obtained crude obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 (:), 4 9 0 0 0 0 1
crystallized from crystallized c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 5 ..();..-•(.);():,,(-), 22 10 0 0 0 0 1
2954, 2856, 2954, 2 29 295 2954 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 7 5 ,,,(-),(.),,(,),,()-; 21 9 0 0 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 (,-):.(,,),.(,,),.(,,-),. 25 9 0 0 0 0 1
(m, 4H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (,,),.(,,-),.-.(,,,,,),. 24 9 0 0 0 0 1
(m, 1H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 5 (,,-),.(,,-);..(.);,.;,.; 25 9 0 0 0 0 1
N, 19.33. n, N N, N, N, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 ,..:,.;,.;,..(-)(.) 19 9 0 0 0 0 1
[M + [m [ [M [M [M BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 5 [](.).. 7 3 0 0 0 0 1
2-[{4-Amino-6-[4-(2-methoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol- 2-[{4-Amino-6-[4-(2-methoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol- 2-[{4-amino-6-[4-(2-methoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-n-(1h-benzo[d]imidazol- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 -[---[-(-)--]-,,---]--(-[]- 27 10 0 0 0 0 1
2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (28). 2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide 2 2( 2(3 2(3H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 8 ()-)----(). 11 5 0 0 0 0 1
Starting Starting starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 0 0 0 0 0 1
from from from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 no 0 0 0 0 0 0 1
N-carbamimidoyl-4-(2-methoxyphenyl)piperazine-1-carboximidamide N-carbamimidoyl-4-(2-methoxyphenyl)piperazine-1-carboximidamide n-carbamimidoyl-4-(2-methoxyphenyl)piperazine-1-carboximidamide N N- N-c N-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 ---(-)-- 8 5 0 0 0 0 1
hydrochloride (0.500 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 (.,.). 6 8 0 0 0 0 1
impurities with impurities i im imp impu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 9 (:)..();..-•(.);():, 20 9 0 0 0 0 1
(N-H), 2955, (n-h), ( (N (N- (N-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 (-),,,(-),,(,),,(),(--)-; 25 9 0 0 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 (,-):.(,,),.(,,),.-.(,,), 25 9 0 0 0 0 1
3.80 (s, 3.80 3 3. 3.8 3.80 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 9 .(,,-),.(,,-),.-.(,,,),.(,,-),. 31 10 0 0 0 0 1
(m, 1H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 9 (,,-),.(,,,);..(.); 19 9 0 0 0 0 1
C, 53.41; c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 9 ,.;,.;,.:,.;,.;,..(-). 22 8 0 0 0 0 1
C 29 c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 7 9 []... 5 5 0 0 0 0 1
2-[{4-Amino-6-[4-(4-nitrophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-Amino-6-[4-(4-nitrophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H-benzo[d]imidazol-2(3H)- 2-[{4-amino-6-[4-(4-nitrophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 -[---[-(-)--]-,,---]--(-[]-()- 30 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (29). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 11 )----(). 8 4 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART SAMEFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ....,, 6 10 0 1 1 0 1
17 of 17 1 17 17 17 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 7 0 no 0 10 0 1 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 0 ---(-)-- 8 8 0 1 0 0 1
(0.524 g, (0.524 ( (0 (0. (0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 0 (.,.). 6 9 0 1 0 0 1
ethanol (1:80), ethanol e et eth etha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 0 (:),..();..-•(.); 17 10 0 1 0 0 1
IR (KBr): ir I IR IR IR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 0 ():,(-),,,(-),,(,),,()-; 24 9 0 1 0 0 1
1 H 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 0 (,-):.(,,),.(,,),.(,, 21 9 0 1 0 0 1
and 2H, and a an and and BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 ,-),.-.(,,),.(,,-),.(,,-),.-.(,,, 33 9 0 0 0 0 1
benzimidazolidine) ppm; benzimidazolidine) b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 7 1 );..(.);,.;,.;,..: 18 10 0 0 0 0 1
C, 50.38; c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 1 ,.;,.;,..(-).[]. 16 9 0 0 0 0 1
found 667.1429. found f fo fou foun BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 7 1 .. 2 1 0 0 0 0 1
2-{[4-Amino-6-(4-benzylpiperazin-1-yl)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)- 2-{[4-Amino-6-(4-benzylpiperazin-1-yl)-1,3,5-triazin-2-yl]methylthio}-N-(1H-benzo[d]imidazol-2(3H)- 2-{[4-amino-6-(4-benzylpiperazin-1-yl)-1,3,5-triazin-2-yl]methylthio}-n-(1h-benzo[d]imidazol-2(3h)- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 2 -[---(---)-,,---]--(-[]-()- 27 10 0 0 0 0 1
ylidene)-4-chloro-5-methylbenzenesulfonamide (30). ylidene)-4-chloro-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 2 )----(). 8 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 7 2 -----(., 8 8 0 0 0 0 1
1.60 mmol). 1.60 1 1. 1.6 1.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 2 .). 3 9 0 0 0 0 1
(1:21) and (1:21) ( (1 (1: (1:2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 2 (:)()..();..-•; 15 9 0 0 0 0 1
IR (KBr): ir I IR IR IR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 7 2 ():,(-),,,,(-),(,),,()-; 24 10 0 0 0 0 1
1 H 1 1 1 1 1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 7 2 (,-):.-.(,,,),.(,,), 20 9 0 0 0 0 1
3.62-3.64 (m, 3.62-3.64 3 3. 3.6 3.62 BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .-.(,,),.(,,-),.-.(,,,),.(,, 28 9 0 0 0 0 1
H-3), 7.99 h-3), H H- H-3 H-3) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 -),.(,,-),.(,,,);(-):., 23 8 0 0 0 0 1
40.55, 42.84, 40.55, 4 40 40. 40.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .,.,.,.,.,.,.,.,.,.,.,.,.,., 28 9 0 0 0 0 1
136.92, 138.41, 136.92, 1 13 136 136. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .,.,.,.,.,.,.;..(.);, 21 10 0 0 0 0 1
54.75; H, 54.75; 5 54 54. 54.7 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 7 4 .;,.;,..:,.;,.;,.. 18 5 0 0 0 0 1
2-[{4-Amino-6-[4-(4-benzhydrylphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H- 2-[{4-Amino-6-[4-(4-benzhydrylphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-N-(1H- 2-[{4-amino-6-[4-(4-benzhydrylphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-n-(1h- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 -[---[-(-)--]-,,---]--(- 24 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (31). benzo[d]imidazol-2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 []-()-)----(). 14 8 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 6 (.,.)----- 10 8 0 0 0 0 1
hydrochloride. The hydrochloride. h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 . 1 9 0 0 0 0 1
(1:22). Yield (1:22). ( (1 (1: (1:2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 (:)..();..-•(.);():,(-),,, 26 8 0 0 0 0 1
(C-H), 1571, (c-h), ( (C (C- (C-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 (-),,,,(,),,()-;(,-): 21 9 0 0 0 0 1
2.20-2.32 (m, 2.20-2.32 2 2. 2.2 2.20 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 .-.(,,,),.(,,),.(,,-),.(,, 26 9 0 0 0 0 1
benzhydryl), 6.87-7.43 benzhydryl), b be ben benz BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 6 ),.-.(,,,),.(,,-),.(,,-),.(,, 29 9 0 0 0 0 1
NH, benzimidazolidine) nh, N NH NH, NH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 6 ,);(-):.,.,.,,.,.,., 20 9 0 0 0 0 1
127.47, 128.06, 127.47, 1 12 127 127. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 .,.,.,.,.,.,.,.,.,.,.,.,.,., 28 10 0 0 0 0 1
174.24 ppm; 174.24 1 17 174 174. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 .;..(.);,.;,.;,..:,.;, 22 10 0 0 0 0 1
4.71; N, 4.71; 4 4. 4.7 4.71 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 6 .;,.. 5 1 0 0 0 0 1
2-[{4-Amino-6-[4-(phenylsulfonyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol- 2-[{4-Amino-6-[4-(phenylsulfonyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-N-(1H-benzo[d]imidazol- 2-[{4-amino-6-[4-(phenylsulfonyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-n-(1h-benzo[d]imidazol- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 -[---[-()--]-,,---]--(-[]- 26 10 0 0 0 0 1
2(3H)-ylidene)-4-chloro-5-methylbenzenesulfonamide (32). 2(3h)-ylidene)-4-chloro-5-methylbenzenesulfonamide 2 2( 2(3 2(3H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 ()-)----(). 11 5 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 ---()-- 7 8 0 0 0 0 1
(0.555 g, (0.555 ( (0 (0. (0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 (.,.). 6 9 0 0 0 0 1
ethanol (1:38) ethanol e et eth etha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 9 (:)(:), 7 8 0 0 0 0 1
(2 × (2 ( (2 (2 (2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 ()()..();...-.•;():,, 21 9 0 0 0 0 1
3211 (N-H), 3211 3 32 321 3211 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 9 (-),,,(-),,(,),,,,(); 21 9 0 0 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 (,-):.(,,),.-.(..,,),.(,,), 27 9 0 0 0 0 1
3.83 (s, 3.83 3 3. 3.8 3.83 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 9 .(,,-),.-.(,,,,-,),.(,,-),.(,, 30 10 0 0 0 0 1
NH, benzimidazolidine) nh, N NH NH, NH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 9 ,);..(.);,.;,.;,.. 18 9 0 0 0 0 1
Found: C, found: F Fo Fou Foun BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 9 :,.;,.;,..(-)(.)[] 18 9 0 0 0 0 1
(686.1193) found (686.1193) ( (6 (68 (686 BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 9 (.).. 5 2 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ....,, 6 10 0 1 1 0 1
18 of 18 1 18 18 18 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 1 0 0 1
3.2.3. General 3.2.3. 3 3. 3.2 3.2. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ...-()--[--,,--- 16 9 0 1 0 0 1
yl]metylthio}-4-chloro-N-(5-fluoro-1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide yl]metylthio}-4-chloro-N-(5-fluoro-1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide yl]metylthio}-4-chloro-n-(5-fluoro-1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide y yl yl] yl]m BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ]----(---[]-()-)-- 18 10 0 1 0 0 1
33-40 33-40 33-40 3 33 33- 33-4 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 - 1 0 0 1 0 0 1
To the to T To To To BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 (.,.) 5 7 0 0 0 0 1
and anhydrous and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 (.),-[---[-(---[]- 18 8 0 0 0 0 1
2(3H)-ylidene)sulfamoyl]-4-methylphenyl}thio]acetate (4) 2(3h)-ylidene)sulfamoyl]-4-methylphenyl}thio]acetate 2 2( 2(3 2(3H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ()-)]--]()(.,.) 15 8 0 0 0 0 1
biguanide hydrochloride biguanide b bi big bigu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 0 (.).. 5 9 0 0 0 0 1
After cooling after A Af Aft Afte BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 0 ,() 3 9 0 0 0 0 1
25 min. 25 2 25 25 25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 . 1 10 0 0 0 0 1
the impurities the t th the the BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 0 . 1 3 0 0 0 0 1
2-{[4-Amino-6-(3,5,5-trimethyl-4,5-dihydro-1H-pyrazol-1-yl)-1,3,5-triazin-2-yl]metylthio}-4-chloro- 2-{[4-Amino-6-(3,5,5-trimethyl-4,5-dihydro-1H-pyrazol-1-yl)-1,3,5-triazin-2-yl]metylthio}-4-chloro- 2-{[4-amino-6-(3,5,5-trimethyl-4,5-dihydro-1h-pyrazol-1-yl)-1,3,5-triazin-2-yl]metylthio}-4-chloro- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 -[---(,,--,-----)-,,---]--- 27 10 0 0 0 0 1
N-(5-fluoro-1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (33). n-(5-fluoro-1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide N N- N-( N-(5 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 1 -(---[]-()-)--(). 17 8 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 2 --,,--,----- 12 8 0 0 0 0 1
hydrochloride (0.372 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 2 (.,.). 6 9 0 0 0 0 1
(1:14). Yield (1:14). ( (1 (1: (1:1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 2 (:)..();..-•;():,,(-),,,(-), 28 9 0 0 0 0 1
1530, 1474 1530, 1 15 153 1530 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 8 2 ,(,),,()-;(,-):.-.(,, 21 9 0 0 0 0 1
CH 3 ch C CH CH CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 2 ),.-.(,,),.-.(,,),.(,,,), 25 9 0 0 0 0 1
3.86 (m, 3.86 3 3. 3.8 3.86 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 2 .(,,-),.-.(,,,,,-),.(,,-),.(,, 30 9 0 0 0 0 1
NH, 5-fluorobenzimidazolidine) nh, N NH NH, NH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 2 ,-);..(.);,.;,.;, 17 10 0 0 0 0 1
21.36. Found: 21.36. 2 21 21. 21.3 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 2 ..:,.;,.;,.. 12 3 0 0 0 0 1
2-{[4-Amino-6-(indolin-1-yl)-1,3,5-triazin-2-yl]metylthio}-4-chloro-N-(5-fluoro-1H-benzo[d]imidazol- 2-{[4-Amino-6-(indolin-1-yl)-1,3,5-triazin-2-yl]metylthio}-4-chloro-N-(5-fluoro-1H-benzo[d]imidazol- 2-{[4-amino-6-(indolin-1-yl)-1,3,5-triazin-2-yl]metylthio}-4-chloro-n-(5-fluoro-1h-benzo[d]imidazol- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 4 -[---(--)-,,---]----(---[]- 27 10 0 0 0 0 1
2(3H)-ylidene)-5-methylbenzenesulfonamide (34). 2(3h)-ylidene)-5-methylbenzenesulfonamide 2 2( 2(3 2(3H BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 4 ()-)--(). 9 4 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 ---(.,.). 9 8 0 0 0 0 1
The title the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 5 (:), 4 9 0 0 0 0 1
second fraction second s se sec seco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 5 ..();..-•;(): 13 10 0 0 0 0 1
3420, 3324, 3420, 3 34 342 3420 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ,,(-),,,(-),,(,),,()-; 22 10 0 0 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 (,-):.(,,),.-.(,.,,-),.-. 25 9 0 0 0 0 1
(m, 2H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 5 (,,-),.-.(,,.,,-),.-.(,,,, 26 9 0 0 0 0 1
1H, H-3), 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 5 ,-),.(,,-),.(,,,-);.. 21 9 0 0 0 0 1
C 26 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 8 5 (.);,.;,.;,..:,.;,.;,.. 23 9 0 0 0 0 1
(ESI-TOF) (596.0980) (esi-tof) ( (E (ES (ESI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 5 (-)(.)[](.).. 13 8 0 0 0 0 1
2-[{4-Amino-6-[(3-chlorophenyl)amino]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-fluoro-1H- 2-[{4-Amino-6-[(3-chlorophenyl)amino]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-fluoro-1H- 2-[{4-amino-6-[(3-chlorophenyl)amino]-1,3,5-triazin-2-yl}methylthio]-4-chloro-n-(5-fluoro-1h- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 -[---[(-)]-,,---]----(--- 25 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (35). benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 7 []-()-)--(). 12 6 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 8 -(-)(.,.). 10 8 0 0 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 (), 3 9 0 0 0 0 1
with water with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 8 (),,..();...-.•;():, 20 9 0 0 0 0 1
(N-H), 2957, (n-h), ( (N (N- (N-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 8 (-),,,(-),,,,(,),,()-; 22 9 0 0 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 (,-):.(,,),.(,,-),.-.(,,,),. 28 10 0 0 0 0 1
(m, 1H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 (,,-),.(,,-),.(,,),.-.(,,,-) 28 9 0 0 0 0 1
ppm; Anal. ppm; p pp ppm ppm; BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 8 8 ;..(.);,.;,.;,..:,.;, 21 9 0 0 0 0 1
3.44; N, 3.44; 3 3. 3.4 3.44 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 .;,..(-)(.)[](.) 16 9 0 0 0 0 1
605.0551. 605.0551. 605.0551. 6 60 605 605. BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 8 .. 2 0 0 0 0 0 1
2-[{4-Amino-6-[(4-chlorophenyl)(methyl)amino]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-fluoro- 2-[{4-Amino-6-[(4-chlorophenyl)(methyl)amino]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-fluoro- 2-[{4-amino-6-[(4-chlorophenyl)(methyl)amino]-1,3,5-triazin-2-yl}metylthio]-4-chloro-n-(5-fluoro- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 -[---[(-)()]-,,---]----(-- 26 10 0 0 0 0 1
1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (36). 1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide 1 1H 1H- 1H-b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 10 -[]-()-)--(). 13 7 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 8 11 -(-)--(.,.). 12 9 0 0 0 0 1
compound was compound c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 8 11 (:)..();..-•; 13 10 0 0 0 0 1
IR (KBr): ir I IR IR IR BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 11 ():,(-),,,(-),,,,(,),, 22 9 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ....,, 6 10 0 1 1 0 1
19 of 19 1 19 19 19 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 8 0 no 0 10 0 1 0 0 1
(SO 2 (so ( (S (SO (SO BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ()-;(,-):.(,,),.(,,-),.(, 25 9 0 1 0 0 1
2H, S-CH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 8 0 ,-),.-.(,,,),.(,,-),.(,,-),.(,, 31 9 0 1 0 0 1
NH, 5-fluorobenzimidazolidine) nh, N NH NH, NH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,-);..(.);,.;,.; 16 10 0 1 0 0 1
N, 18.09. n, N N, N, N, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 ,..:,.;,.;,..(-). 17 9 0 1 0 0 1
[M + [m [ [M [M [M BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 8 0 []... 5 3 0 1 0 0 1
2-[{[4-Amino-6-(4-phenylpiperazin-1-yl)-1,3,5-triazin-2-yl]methyl}thio]-4-chloro-N-(5-fluoro-1H- 2-[{[4-Amino-6-(4-phenylpiperazin-1-yl)-1,3,5-triazin-2-yl]methyl}thio]-4-chloro-N-(5-fluoro-1H- 2-[{[4-amino-6-(4-phenylpiperazin-1-yl)-1,3,5-triazin-2-yl]methyl}thio]-4-chloro-n-(5-fluoro-1h- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 -[[---(---)-,,---]]----(--- 27 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (37). benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 1 []-()-)--(). 12 6 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 -----(., 8 8 0 0 0 0 1
1.60 mmol). 1.60 1 1. 1.6 1.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 .).(: 5 9 0 0 0 0 1
2.5), a 2.5), 2 2. 2.5 2.5) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 .),..();..-•; 13 10 0 0 0 0 1
(KBr): 3309, (kbr): ( (K (KB (KBr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 ():,,(-),,,,(-),,,,(,),, 24 9 0 0 0 0 1
1137 (SO 1137 1 11 113 1137 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 9 2 ()-;(,-):.(,,),.(,,),. 22 9 0 0 0 0 1
(m, 4H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 (,,),.(,,-),.-.(,,,),.(,,-),. 29 10 0 0 0 0 1
(m, 1H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 (,,-),.(,,,-);.. 16 9 0 0 0 0 1
(640.15); C, (640.15); ( (6 (64 (640 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 (.);,.;,.;,..:,.;,.;,..(-). 27 9 0 0 0 0 1
for C for f fo for for BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 []... 5 5 0 0 0 0 1
2-[{4-Amino-6-[4-(4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-fluoro-1H- 2-[{4-Amino-6-[4-(4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-fluoro-1H- 2-[{4-amino-6-[4-(4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-n-(5-fluoro-1h- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 -[---[-(-)--]-,,---]----(--- 28 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (38). benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 []-()-)--(). 12 6 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 4 ---(-)-- 8 8 0 0 0 0 1
(0.481 g, (0.481 ( (0 (0. (0.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 (.,.). 6 8 0 0 0 0 1
boiling ethanol boiling b bo boi boil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 4 (:)..();..-•(.);():,,(-), 25 9 0 0 0 0 1
2956, 2921, 2956, 2 29 295 2956 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 4 ,,(-),,,(,),,()-;(, 19 9 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 -):.(,,),.(,,),.(,.,,),.(, 26 9 0 0 0 0 1
2H, S-CH 2h, 2 2H 2H, 2H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 4 ,-),.-.(,,,),.(,,-),.(,,-),.(,, 31 9 0 0 0 0 1
NH, 5-fluorobenzimidazolidine) nh, N NH NH, NH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 ,-);..(.);,.;,.; 16 10 0 0 0 0 1
N, 19.15. n, N N, N, N, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 ,..:,.;,.;,..(-). 17 9 0 0 0 0 1
[M + [m [ [M [M [M BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 4 []... 5 3 0 0 0 0 1
2-[{4-Amino-6-[4-(4-chlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-fluoro-1H- 2-[{4-Amino-6-[4-(4-chlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-fluoro-1H- 2-[{4-amino-6-[4-(4-chlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-n-(5-fluoro-1h- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 -[---[-(-)--]-,,---]----(--- 28 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (39). benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 []-()-)--(). 12 6 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 7 ---(-)-- 8 8 0 0 0 0 1
(0.508 g, (0.508 ( (0 (0. (0.5 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 (.,.). 6 9 0 0 0 0 1
ethanol (1:4.5), ethanol e et eth etha BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 (:.),..(); 10 9 0 0 0 0 1
m.p. 198-199 m.p. m m. m.p m.p. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 ..-•;():,(-),,,(-),,(,),, 25 9 0 0 0 0 1
1131 (SO 1131 1 11 113 1131 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 9 7 ()-;(,-):.(,,),.(,,),.-. 24 9 0 0 0 0 1
(m, 4H (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 7 (,,-),.-.(,,,),.(,,-),.(,, 26 9 0 0 0 0 1
H-6), 10.70 h-6), H H- H-6 H-6) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 7 -),.(,,,-);..(.); 17 10 0 0 0 0 1
C, 49.85; c, C C, C, C, BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 7 ,.;,.;,..:,.;,.;,.. 19 5 0 0 0 0 1
2-[{4-Amino-6-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N- 2-[{4-Amino-6-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N- 2-[{4-amino-6-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-n- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 -[---[-(,-)--]-,,---]---- 25 10 0 0 0 0 1
(5-fluoro-1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (40). (5-fluoro-1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide ( (5 (5- (5-f BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 9 (---[]-()-)--(). 16 8 0 0 0 0 1
Starting Starting starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 0 0 0 0 0 1
from from from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 no 0 0 0 0 0 0 1
N-carbamimidoyl-4-(3,4-dichlorophenyl)piperazine-1-carboximidamide N-carbamimidoyl-4-(3,4-dichlorophenyl)piperazine-1-carboximidamide n-carbamimidoyl-4-(3,4-dichlorophenyl)piperazine-1-carboximidamide N N- N-c N-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 ---(,-)-- 9 6 0 0 0 0 1
hydrochloride (0.563 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 (.,.)., 7 8 0 0 0 0 1
the filtrate the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 ,(),, 5 8 0 0 0 0 1
and then and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 10 ..();..-•;():, 14 9 0 0 0 0 1
3292, 3116 3292, 3 32 329 3292 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 ,(-),,,(-),,,,(,),, 19 8 0 0 0 0 1
(SO 2 (so ( (S (SO (SO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 10 ()-;(,-):.(,,),.(,,),.-. 24 10 0 0 0 0 1
(m, 4H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 10 (,,),.(,,-),.-.(,,,),.(,, 25 9 0 0 0 0 1
H-3), 7.97 h-3), H H- H-3 H-3) BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 10 -),.(,,-),.(,,,-);.. 20 8 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 ....,, 6 10 0 1 1 0 1
20 of 20 2 20 20 20 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 9 0 no 0 10 0 1 0 0 1
C 28 c C C C C BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 0 (.);,.;,.;,..:,.;,.;,.. 23 10 0 1 0 0 1
(ESI-TOF) (707.0622) (esi-tof) ( (E (ES (ESI BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 0 (-)(.)[](.)... 14 9 0 1 0 0 1
Procedure for procedure P Pr Pro Proc BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 -()--[--,,---]---- 18 9 0 1 0 0 1
(5-chloro-1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfon-amide 41-49. (5-chloro-1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfon-amide ( (5 (5- (5-c BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 (---[]-()-)----. 16 7 0 1 0 0 1
To the to T To To To BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 0 (.,.) 5 7 0 1 0 0 1
and anhydrous and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 (.)-[---[-(---[]- 17 7 0 1 0 0 1
2(3H)-ylidene)sulfamoyl]-4-methylphenyl}thio]acetate (5) 2(3h)-ylidene)sulfamoyl]-4-methylphenyl}thio]acetate 2 2( 2(3 2(3H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 ()-)]--]()(.,.) 15 8 0 1 0 0 1
biguanide hydrochloride biguanide b bi big bigu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 0 (.). 4 8 0 1 0 0 1
for 45 for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 .,, 3 9 0 1 0 0 1
(25 mL) (25 ( (2 (25 (25 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 0 (). 3 9 0 1 0 0 1
by extraction by b by by by BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 0 . 1 5 0 1 0 0 1
2-{[4-Amino-6-(3,5,5-trimethyl-4,5-dihydro-1H-pyrazol-1-yl)-1,3,5-triazin-2-yl]metylthio}-4-chloro-N- 2-{[4-Amino-6-(3,5,5-trimethyl-4,5-dihydro-1H-pyrazol-1-yl)-1,3,5-triazin-2-yl]metylthio}-4-chloro-N- 2-{[4-amino-6-(3,5,5-trimethyl-4,5-dihydro-1h-pyrazol-1-yl)-1,3,5-triazin-2-yl]metylthio}-4-chloro-n- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 -[---(,,--,-----)-,,---]---- 28 10 0 0 0 0 1
(5-chloro-1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (41). (5-chloro-1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide ( (5 (5- (5-c BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 (---[]-()-)--(). 16 7 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 2 --,,--,----- 12 8 0 0 0 0 1
hydrochloride (0.372 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 2 (.,.). 6 8 0 0 0 0 1
mixture of mixture m mi mix mixt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 2 /(:)..();..-•;():,(-), 22 9 0 0 0 0 1
2965, 2921, 2965, 2 29 296 2965 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 9 2 ,,(-),,,(,),,()-;(, 19 9 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 -):.-.(,,),.-.(,,,),.(,,), 26 10 0 0 0 0 1
2.78-2.80 (m, 2.78-2.80 2 2. 2.7 2.78 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 .-.(,,,),.(,,-),.-.(,,, 23 9 0 0 0 0 1
1H, H-3), 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 2 ,-),.(,,-),.(,,,-);.. 21 8 0 0 0 0 1
C 24 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 2 (.);,.;,.;,..:,.;,.;,.. 23 9 0 0 0 0 1
(ESI-TOF) 605.0950 (esi-tof) ( (E (ES (ESI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 2 (-).[]... 9 8 0 0 0 0 1
2-{[4-Amino-6-(phenylamino)-1,3,5-triazin-2-yl]methylthio}-4-chloro-N-(5-chloro-1H-benzo[d]imidazol-2(3H)- 2-{[4-Amino-6-(phenylamino)-1,3,5-triazin-2-yl]methylthio}-4-chloro-N-(5-chloro-1H-benzo[d]imidazol-2(3H)- 2-{[4-amino-6-(phenylamino)-1,3,5-triazin-2-yl]methylthio}-4-chloro-n-(5-chloro-1h-benzo[d]imidazol-2(3h)- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 -[---()-,,---]----(---[]-()- 28 10 0 0 0 0 1
ylidene)-5-methylbenzenesulfonamide (42). ylidene)-5-methylbenzenesulfonamide y yl yli ylid BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 )--(). 6 3 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 5 -(.,.). 7 8 0 0 0 0 1
obtained after obtained o ob obt obta BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 (:.), 5 9 0 0 0 0 1
crystallized from crystallized c cr cry crys BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 5 ..();..-•;():,(-),, 19 9 0 0 0 0 1
(C-H), 1597, (c-h), ( (C (C- (C-H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 (-),,,(,),,()-:(,-):. 21 9 0 0 0 0 1
(s, 3H, (s, ( (s (s, (s, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 5 (,,),.(,,-),.-.(,,,,-),.(,, 27 9 0 0 0 0 1
H-6), 10.89 h-6), H H- H-6 H-6) BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 5 -),.(,,,-);..(.); 17 10 0 0 0 0 1
C, 49.06; c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 5 ,.;,.;,..:,.;,.;,..(-). 23 9 0 0 0 0 1
C 24 c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 5 []... 5 5 0 0 0 0 1
2-[{4-Amino-6-[(4-fluorophenyl)amino]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-chloro-1H- 2-[{4-Amino-6-[(4-fluorophenyl)amino]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-chloro-1H- 2-[{4-amino-6-[(4-fluorophenyl)amino]-1,3,5-triazin-2-yl}methylthio]-4-chloro-n-(5-chloro-1h- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 -[---[(-)]-,,---]----(--- 25 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (43). benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 []-()-)--(). 12 6 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 9 8 -(-)(.,.). 10 8 0 0 0 0 1
reaction mixture reaction r re rea reac BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 (), 3 9 0 0 0 0 1
with water with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 9 8 (),,,..();.. 12 9 0 0 0 0 1
270.1-271.4 • 270.1-271.4 2 27 270 270. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 .-.•;():,(-),,,,(-),,(,),, 26 9 0 0 0 0 1
1140 (SO 1140 1 11 114 1140 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 9 8 ()-;(,-):.(,,),.(,,-),.-. 25 9 0 0 0 0 1
(m, 7H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 9 8 (,,,),.(,,-),.(,,-),.(,,,---), 30 9 0 0 0 0 1
12.06-12.10 (m, 12.06-12.10 1 12 12. 12.0 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 9 8 .-.(,,,-);..(.); 16 10 0 0 0 0 1
C, 47.61; c, C C, C, C, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 9 8 ,.;,.;,..:,.;,.;,..(-)(.) 25 9 0 0 0 0 1
C 24 c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 9 8 [](.).. 7 5 0 0 0 0 1
2-[{4-Amino-6-[(4-methoxyphenyl)amino]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-chloro-1H- 2-[{4-Amino-6-[(4-methoxyphenyl)amino]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-chloro-1H- 2-[{4-amino-6-[(4-methoxyphenyl)amino]-1,3,5-triazin-2-yl}methylthio]-4-chloro-n-(5-chloro-1h- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 11 -[---[(-)]-,,---]----(--- 25 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (44). benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 11 []-()-)--(). 12 6 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 11 -(-)(.,.). 10 8 0 0 0 0 1
compound was compound c co com comp BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 11 (:), 4 10 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ....,, 6 10 0 1 1 0 1
21 of 21 2 21 21 21 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 0 no 0 10 0 1 0 0 1
fraction of fraction f fr fra frac BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 0 ..();..-•;(): 13 8 0 1 0 0 1
3350, 3178 3350, 3 33 335 3350 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ,(-),,,(-),,(,),,()-; 21 9 0 1 0 0 1
(500 MHz, (500 ( (5 (50 (500 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 (,-):.(,,),.(,,),.(,,-),.-.(,, 30 9 0 1 0 0 1
H Ar h H H H H BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 ,,-),.(,,-),.(,,,---),.(,, 26 9 0 1 0 0 1
NH, 5-chlorobenzimidazolidine) nh, N NH NH, NH, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,-);..(.);,.;,.;, 17 10 0 1 0 0 1
18.15. Found: 18.15. 1 18 18. 18.1 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 ..:,.;,.;,.. 12 3 0 1 0 0 1
2-[{4-Amino-6-[4-(4-phenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-chloro-1H- 2-[{4-Amino-6-[4-(4-phenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-chloro-1H- 2-[{4-amino-6-[4-(4-phenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-n-(5-chloro-1h- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 -[---[-(-)--]-,,---]----(--- 28 10 0 0 0 0 1
benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (45). benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide b be ben benz BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 []-()-)--(). 12 6 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 2 -----(., 8 8 0 0 0 0 1
1.60 mmol). 1.60 1 1. 1.6 1.60 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 2 .). 3 9 0 0 0 0 1
(1:4.5), a (1:4.5), ( (1 (1: (1:4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 2 (:.),..();..- 13 10 0 0 0 0 1
• C; • • • • • BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 2 •;():,(-),,,,(-),,(,),, 23 9 0 0 0 0 1
(SO 2 (so ( (S (SO (SO BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 3 ()-;(,-):.(,,-),.-.(,,),.-. 27 10 0 0 0 0 1
(m, 4H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 3 (,,),.(,,-),.-.(,,,),.(,,-),. 29 9 0 0 0 0 1
(m, 1H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 3 (,,-),.(,,,-);.. 16 9 0 0 0 0 1
(656.51); C, (656.51); ( (6 (65 (656 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 3 (.);,.;,.;,..:,.;,.;,..(-). 27 9 0 0 0 0 1
for C for f fo for for BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 3 []... 5 5 0 0 0 0 1
2-[{4-Amino-6-[4-(4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-chloro- 2-[{4-Amino-6-[4-(4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-N-(5-chloro- 2-[{4-amino-6-[4-(4-fluorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}metylthio]-4-chloro-n-(5-chloro- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 -[---[-(-)--]-,,---]----(-- 27 10 0 0 0 0 1
1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (46). 1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide 1 1H 1H- 1H-b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 -[]-()-)--(). 13 6 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ---(-)-- 8 8 0 0 0 0 1
(0.481 g, (0.481 ( (0 (0. (0.4 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 (.,.). 6 8 0 0 0 0 1
boiling ethanol boiling b bo boi boil BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 (:)..();..-•;():,,(-),, 23 9 0 0 0 0 1
2900, 2867 2900, 2 29 290 2900 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 10 5 ,(-),,,,(,),,()-;(, 19 9 0 0 0 0 1
DMSO-d 6 dmso-d D DM DMS DMSO BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 -):.(,,),.(,,),.-.(,,),.(,, 27 9 0 0 0 0 1
S-CH 2 s-ch S S- S-C S-CH BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 -),.-.(,,,),.(,,-),.(,,-),.(,,, 31 9 0 0 0 0 1
5-chlorobenzimidazolidine) ppm; 5-chlorobenzimidazolidine) 5 5- 5-c 5-ch BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 -);..(.);,.;,.;, 16 10 0 0 0 0 1
18.69. Found: 18.69. 1 18 18. 18.6 BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 5 ..:,.;,.;,.. 12 3 0 0 0 0 1
2-{[4-Amino-6-{4-[4-(trifluoromethyl)phenyl]piperazin-1-yl}-1,3,5-triazin-2-yl]methylthio}-4-chloro-N-(5- 2-{[4-Amino-6-{4-[4-(trifluoromethyl)phenyl]piperazin-1-yl}-1,3,5-triazin-2-yl]methylthio}-4-chloro-N-(5- 2-{[4-amino-6-{4-[4-(trifluoromethyl)phenyl]piperazin-1-yl}-1,3,5-triazin-2-yl]methylthio}-4-chloro-n-(5- 2 2- 2-{ 2-{[ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 -[----[-()]---,,---]----(- 26 10 0 0 0 0 1
chloro-1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (47). chloro-1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide c ch chl chlo BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 --[]-()-)--(). 14 7 0 0 0 0 1
Starting from starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 7 ---[-()]-- 10 8 0 0 0 0 1
hydrochloride (0.561 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 (.,.)...();.. 13 8 0 0 0 0 1
215.0-215.7 • 215.0-215.7 2 21 215 215. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 .-.•;():,(-),,,(-),,,(,),, 26 10 0 0 0 0 1
1132 (SO 1132 1 11 113 1132 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 10 7 ()-;(,-):.(,,),.(,,),. 22 9 0 0 0 0 1
(m, 4H, (m, ( (m (m, (m, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 (,,,-),.-.(,,,),.(,,-),.(, 26 9 0 0 0 0 1
1H, H-6), 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 ,-),.(,,,-);.. 14 10 0 0 0 0 1
(724.61); C, (724.61); ( (7 (72 (724 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 7 (.);,.;,.;,..:,.;,.;,..(-)(.) 29 9 0 0 0 0 1
calcd for calcd c ca cal calc BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 7 [](.).. 7 7 0 0 0 0 1
2-[{4-Amino-6-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-chloro- 2-[{4-Amino-6-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-chloro- 2-[{4-amino-6-[4-(3,4-dichlorophenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-4-chloro-n-(5-chloro- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 9 -[---[-(,-)--]-,,---]----(-- 28 10 0 0 0 0 1
1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (48). 1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide 1 1H 1H- 1H-b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 9 -[]-()-)--(). 13 6 0 0 0 0 1
Starting Starting starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 0 0 0 0 0 1
from from from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 no 0 0 0 0 0 0 1
N-carbamimidoyl-4-(3,4-dichlorophenyl)piperazine-1-carboximidamide N-carbamimidoyl-4-(3,4-dichlorophenyl)piperazine-1-carboximidamide n-carbamimidoyl-4-(3,4-dichlorophenyl)piperazine-1-carboximidamide N N- N-c N-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 ---(,-)-- 9 6 0 0 0 0 1
hydrochloride (0.445 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 10 (.,.). 6 8 0 0 0 0 1
impurities with impurities i im imp impu BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 10 /(:.)..();...-. 15 9 0 0 0 0 1
• C; • • • • • BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 10 •;():,,(-),,,,(-),,(,),, 24 10 0 0 0 0 1
(SO 2 (so ( (S (SO (SO BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 10 ()-;(,-):.(,,),.(,,),.-.(, 26 9 0 0 0 0 1
4H, piperazine 4h, 4 4H 4H, 4H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 ,,-),.-.(,,,),.(,,-),.(,, 25 9 0 0 0 0 1
H-6), 10.79 h-6), H H- H-6 H-6) BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 10 -),.(,,,-);..(.); 17 10 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ....,, 6 10 0 1 1 0 1
22 of 22 2 22 22 22 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 0 no 0 10 0 1 0 0 1
C, 46.35; c, C C, C, C, BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 0 ,.;,.;,..:,.;,.;,..(-)(.) 25 10 0 1 0 0 1
C 28 c C C C C BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 0 [](.).. 7 6 0 1 0 0 1
2-[{4-Amino-6-[4-(2-methoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-chloro- 2-[{4-Amino-6-[4-(2-methoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-4-chloro-N-(5-chloro- 2-[{4-amino-6-[4-(2-methoxyphenyl)piperazin-1-yl]-1,3,5-triazin-2-yl}methylthio]-4-chloro-n-(5-chloro- 2 2- 2-[ 2-[{ BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -[---[-(-)--]-,,---]----(-- 27 10 0 0 0 0 1
1H-benzo[d]imidazol-2(3H)-ylidene)-5-methylbenzenesulfonamide (49). 1h-benzo[d]imidazol-2(3h)-ylidene)-5-methylbenzenesulfonamide 1 1H 1H- 1H-b BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 0 -[]-()-)--(). 13 6 0 0 0 0 1
Starting Starting starting S St Sta Star BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 1 no 0 0 0 0 0 0 1
from from from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 no 0 0 0 0 0 0 1
N-carbamimidoyl-4-(2-methoxyphenyl)piperazine-1-carboximidamide N-carbamimidoyl-4-(2-methoxyphenyl)piperazine-1-carboximidamide n-carbamimidoyl-4-(2-methoxyphenyl)piperazine-1-carboximidamide N N- N-c N-ca BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 ---(-)-- 8 5 0 0 0 0 1
hydrochloride (0.501 hydrochloride h hy hyd hydr BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 1 (.,.). 6 8 0 0 0 0 1
from a from f fr fro from BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 1 /(:)..();...-.•;():, 20 9 0 0 0 0 1
3320 (N-H), 3320 3 33 332 3320 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 1 (-),,,,(-),,(,),,()-; 21 9 0 0 0 0 1
NMR (500 nmr N NM NMR NMR BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 1 (,-):.(,,),.-.(,,),.-.(,, 25 9 0 0 0 0 1
piperazine), 3.80 piperazine), p pi pip pipe BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 1 ),.(,,-),.(,,-),.-.(,,,),.(, 28 10 0 0 0 0 1
1H, H-3), 1h, 1 1H 1H, 1H, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 1 ,-),.(,,-),.(,,,-);.. 21 8 0 0 0 0 1
C 29 c C C C C BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 10 1 (.);,.;,.;,..:,.;,.;,.. 23 10 0 0 0 0 1
(ESI-TOF) (685.1212) (esi-tof) ( (E (ES (ESI BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 1 (-)(.)[](.).. 13 8 0 0 0 0 1
3.3. Cell 3.3. 3 3. 3.3 3.3. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 10 4 .. 2 10 0 0 0 0 1
All chemicals, all A Al All All BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 ,,-(.,,). 9 8 0 0 0 0 1
The HCT-116 the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 -(-:-),-, 9 8 0 0 0 0 1
and HaCaT and a an and and BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 (,). 4 8 0 0 0 0 1
cultured in cultured c cu cul cult BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 ''(), 5 8 0 0 0 0 1
2 mM 2 2 2 2 2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 1 0 0 0 0 0 0 0 10 5 ,/,/. 5 9 0 0 0 0 1
humidified atmosphere humidified h hu hum humi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 •(,). 5 8 0 0 0 0 1
Cell viability cell C Ce Cel Cell BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 10 5 (-(,---)-,- 11 8 0 0 0 0 1
bromide) assay. bromide) b br bro brom BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 10 5 ).-/ 4 10 0 0 0 0 1
with the with w wi wit with BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 -(,,,)., 8 9 0 0 0 0 1
MTT (0.5 mtt M MT MTT MTT BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 10 5 (./)•. 6 9 0 0 0 0 1
next stage, next n ne nex next BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 , 1 9 0 0 0 0 1
550 nm 550 5 55 550 550 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 10 5 (,,,). 6 8 0 0 0 0 1
was performed was w wa was was BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 . 1 8 0 0 0 0 1
experiments. Cisplatin experiments. e ex exp expe BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 10 5 .. 2 5 0 0 0 0 1
3.4. Molecular 3.4. 3 3. 3.4 3.4. BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 .. 2 10 0 0 0 0 1
All the all A Al All All BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 no 0 8 0 0 0 0 1
(MOE, 2018) (moe, ( (M (MO (MOE BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 8 (,).. 5 9 0 0 0 0 1
performed with performed p pe per perf BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ./( 3 9 0 0 0 0 1
below 2.0 below b be bel belo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ./). 4 7 0 0 0 0 1
The X-ray the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 ---(:) 6 9 0 0 0 0 1
downloaded from downloaded d do dow down BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 8 ://../. 7 9 0 0 0 0 1
For each for F Fo For For BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 -, 2 9 0 0 0 0 1
were removed. were w we wer were BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 . 1 9 0 0 0 0 1
protein. The protein. p pr pro prot BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 .-(-). 6 9 0 0 0 0 1
Triangle Matcher triangle T Tr Tri Tria BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 8 , 1 9 0 0 0 0 1
1000 poses 1000 1 10 100 1000 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 1 0 0 0 11 8 (). 3 9 0 0 0 0 1
molecular docking molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 ,. 2 10 0 0 0 0 1
that had that t th tha that BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 . 1 9 0 0 0 0 1
poses also poses p po pos pose BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 no 0 9 0 0 0 0 1
MDM2 (pdb: mdm2 M MD MDM MDM2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 8 (:)-., 6 9 0 0 0 0 1
the bond the t th the the BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 8 . 1 3 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ....,, 6 10 0 1 1 0 1
23 of 23 2 23 23 23 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 no 0 10 0 1 0 0 1
4. Conclusions 4. 4 4. 4. 4. BLOCKSTART PAGEIN NEWFONT HIGHERFONT 1 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 . 1 10 0 1 0 0 1
We have we W We We We BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 -[(----,,---)]---- 18 9 0 0 0 0 1
methyl-N-(5-R 1 methyl-n-(5-r m me met meth BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 --(---[]-()-)-. 15 7 0 0 0 0 1
The obtained the T Th The The BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 1 0 0 0 0 1
compounds were compounds c co com comp BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ,, 2 9 0 0 0 0 1
colon (HCT-116), colon c co col colo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 0 (-),(-)()(:-;- 14 9 0 0 0 0 1
11-18 µM), 11-18 1 11 11- 11-1 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 -),.-()(:),. 12 9 0 0 0 0 1
linear regression linear l li lin line BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 () 2 8 0 0 0 0 1
cytotoxic activity cytotoxic c cy cyt cyto BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 ,()() 5 9 0 0 0 0 1
molecular descriptors. molecular m mo mol mole BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 8 0 0 0 0 1
further development further f fu fur furt BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 10 0 0 0 0 1
docking studies docking d do doc dock BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 9 0 0 0 0 1
the active the t th the the BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 no 0 9 0 0 0 0 1
tested compounds. tested t te tes test BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 . 1 1 0 0 0 0 1
Supplementary Materials: supplementary S Su Sup Supp BLOCKSTART PAGEIN NEWFONT LOWERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 3 :://../-////. 13 10 0 0 0 0 1
Author Contributions: author A Au Aut Auth BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 3 :....,..,.., 12 9 0 0 0 0 1
J.S. and j.s. J J. J.S J.S. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 ....,..,.... 12 10 0 0 0 0 1
QSAR and qsar Q QS QSA QSAR BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 3 .. 2 8 0 0 0 0 1
Funding: The funding: F Fu Fun Fund BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 :...--/-- 9 10 0 0 0 0 1
Union through union U Un Uni Unio BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 no 0 8 0 0 0 0 1
Development 2014-2020. development D De Dev Deve BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 1 1 0 0 0 0 0 11 4 -. 2 2 0 0 0 0 1
Conflicts of conflicts C Co Con Conf BLOCKSTART PAGEIN SAMEFONT SAMEFONTSIZE 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 :. 2 10 0 0 0 0 1
References References references R Re Ref Refe BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 1 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 no 0 10 0 0 0 0 1
1. 1. 1. 1 1. 1. 1. BLOCKSTART PAGEIN NEWFONT LOWERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Siegel, R.L.; siegel, S Si Sie Sieg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,..;,..;,.,...,,-.[] 20 9 0 0 0 0 1
[PubMed] [PubMed] [pubmed] [ [P [Pu [Pub BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 4 [] 2 0 0 0 0 0 1
2. 2. 2. 2 2. 2. 2. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
American Cancer american A Am Ame Amer BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 .-; 3 8 0 0 0 0 1
Society: Atlanta, society: S So Soc Soci BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 4 :,,,. 5 2 0 0 0 0 1
3. 3. 3. 3 3. 3. 3. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Wang, S.; wang, W Wa Wan Wang BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,.;,.;,.;,.;,..-- 17 9 0 0 0 0 1
for new for f fo for for BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 4 :....,,. 8 8 0 0 0 0 1
[CrossRef] [PubMed] [crossref] [ [C [Cr [Cro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 4 [][] 4 1 0 0 0 0 1
4. 4. 4. 4 4. 4. 4. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Burgess, A.; burgess, B Bu Bur Burg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,.;,..;,.;,.;,.;,./- 20 8 0 0 0 0 1
therapies. Front. therapies. t th the ther BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 4 ...,,-.[][] 11 5 0 0 0 0 1
5. 5. 5. 5 5. 5. 5. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Kussie, P.H.; kussie, K Ku Kus Kuss BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,..;,.;,.;,.;,.;,..;,.. 23 9 0 0 0 0 1
MDM2 oncoprotein mdm2 M MD MDM MDM2 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 .,,-. 5 8 0 0 0 0 1
[CrossRef] [PubMed] [crossref] [ [C [Cr [Cro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 4 [][] 4 1 0 0 0 0 1
6. 6. 6. 6 6. 6. 6. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Vogelstein, B.; vogelstein, V Vo Vog Voge BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,.;,.;,...,,-.[][] 18 9 0 0 0 0 1
7. 7. 7. 7 7. 7. 7. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Abdel-Fattah, G.; abdel-fattah, A Ab Abd Abde BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 -,.;,.;,.;,.;,./ 16 8 0 0 0 0 1
development of development d de dev deve BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 1 1 0 0 0 0 0 11 4 ....,,-.[] 10 8 0 0 0 0 1
8. 8. 8. 8 8. 8. 8. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Capoulade, C.; capoulade, C Ca Cap Capo BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,.;-,.;,.;,.;,.;,.;,. 21 10 0 0 0 0 1
of MDM2, of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 4 ,,-'. 5 9 0 0 0 0 1
Oncogene 1998, oncogene O On Onc Onco BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,,-.[] 6 3 0 0 0 0 1
9. 9. 9. 9 9. 9. 9. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 . 1 0 0 0 0 0 1
Gorgoulis, V.G.; gorgoulis, G Go Gor Gorg BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,..;,.;,.;,.;,.;,.;,.;,.; 25 10 0 0 0 0 1
Garinis, G.; garinis, G Ga Gar Gari BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,.;,.;., 8 9 0 0 0 0 1
exert a exert e ex exe exer BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 4 - 1 8 0 0 0 0 1
(NSCLCs). Mol. (nsclcs). ( (N (NS (NSC BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 4 ()...,,-.[] 11 4 0 0 0 0 1
10. Bueso-Ramos, 10. 1 10 10. 10. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 .-,..;,.;,..;,.;,.;,.;,.;,.; 28 9 0 0 0 0 1
Albitar, M. albitar, A Al Alb Albi BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 4 ,.-...,,-. 10 9 0 0 0 0 1
11. Liu, 11. 1 11 11. 11. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 4 .,.;,.;,.;,.;,.;,., 19 9 0 0 0 0 1
small-molecule drugs small-molecule s sm sma smal BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 4 --/.....,,-. 12 8 0 0 0 0 1
[CrossRef] [CrossRef] [crossref] [ [C [Cr [Cro BLOCKEND PAGEEND SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 4 [] 2 0 0 0 0 0 1
Int. J. int. I In Int Int. BLOCKSTART PAGESTART NEWFONT LOWERFONT 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ....,, 6 10 0 0 1 0 1
24 of 24 2 24 24 24 BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS ALLDIGIT 0 0 0 0 0 0 0 0 11 0 no 0 10 0 0 0 0 1
12. Vassilev, 12. 1 12 12. 12. BLOCKSTART PAGEIN SAMEFONT HIGHERFONT 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..;,..;,.;,.;,.;,.;,.;,.;,.; 30 9 1 1 0 0 1
Klein, C.; klein, K Kl Kle Klei BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ,.;.-., 7 8 1 1 0 0 1
303, 844-848. 303, 3 30 303 303, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,-.[][] 7 2 1 1 0 0 1
13. Tisato, 13. 1 13 13. 13. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.;,.;,.;,.;,./: 17 9 1 1 0 0 1
Perspectives for perspectives P Pe Per Pers BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 1 0 0 0 0 0 11 0 .... 4 8 1 1 0 0 1
2017, 10, 2017, 2 20 201 2017 BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 1 0 0 0 11 0 ,,.[][] 7 2 1 1 0 0 1
14. Sławi 14. 1 14 14. 14. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.------,--,,-. 16 9 1 1 0 0 1
Pol. J. pol. P Po Pol Pol. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ...,,-. 7 2 1 1 0 0 1
15. Liu, 15. 1 15 15. 15. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..;,..-.., 12 9 1 1 0 0 1
46, 7921-7922. 46, 4 46 46, 46, BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 ,-.[] 5 2 1 1 0 0 1
16. Konstantinov, 16. 1 16 16. 16. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.;,.;,.;,. 12 9 1 1 0 0 1
diversely substituted diversely d di div dive BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -....,,-.[] 11 7 1 1 0 0 1
17. Patel, 17. 1 17 17. 17. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..;,.;,.;,..;,.-.;,.-.;,.-.;,.-. 34 10 1 1 0 0 1
conjugates as conjugates c co con conj BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .....,,-.[] 11 8 1 1 0 0 1
18. Kommula, 18. 1 18 18. 18. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.;,.;,.;,... 14 9 1 1 0 0 1
novel 4-substituted novel n no nov nove BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -....,,-. 9 9 1 1 0 0 1
[CrossRef] [CrossRef] [crossref] [ [C [Cr [Cro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 [] 2 0 1 1 0 0 1
19. Guariento, 19. 1 19 19. 19. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.;,.;,.;,..;,..;,., 21 9 1 1 0 0 1
chemical synthesis chemical c ch che chem BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 - 1 9 1 1 0 0 1
of TAAR1 of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 .....,,-.[] 11 5 1 1 0 0 1
20. Ma, 20. 2 20 20. 20. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,.;,..;,...;,.-.,--,,- 23 9 1 1 0 0 1
derivatives as derivatives d de der deri BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -.....,,-. 10 8 1 1 0 0 1
[CrossRef] [CrossRef] [crossref] [ [C [Cr [Cro BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 [] 2 0 1 1 0 0 1
21. Trejo-Soto, 21. 2 21 21. 21. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .-,..;-,.;-,.;-,..;,. 21 8 1 1 0 0 1
of AKT of o of of of BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 :-,, 4 8 1 1 0 0 1
studies of studies s st stu stud BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 ,,-.....,,-.[] 14 7 1 1 0 0 1
22. Kaboli, 22. 2 22 22. 22. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..;,.;,.-.,, 14 9 1 1 0 0 1
berberine derivatives: berberine b be ber berb BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 0 0 0 0 0 0 11 0 :.,,. 5 8 1 1 0 0 1
23. Reddy, 23. 2 23 23. 23. BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP CONTAINSDIGITS 0 0 0 0 0 0 0 0 11 0 .,..;,..;,.;,..;,..;,..,, 25 9 1 1 0 0 1
dynamics and dynamics d dy dyn dyna BLOCKIN PAGEIN SAMEFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 0 -.. 3 8 1 1 0 0 1
Comput. Aided comput. C Co Com Comp BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 INITCAP NODIGIT 0 0 0 0 0 0 0 0 11 0 ..,,-.[][] 10 5 1 1 0 0 1
© 2020 © © © © © BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 1 0 0 0 0 0 0 0 11 11 .,,. 4 10 1 1 0 0 1
article distributed article a ar art arti BLOCKSTART PAGEIN NEWFONT SAMEFONTSIZE 0 0 NOCAPS NODIGIT 0 0 1 0 0 0 0 0 11 11 no 0 10 1 1 0 0 1
(CC BY) (cc ( (C (CC (CC BLOCKEND PAGEIN SAMEFONT SAMEFONTSIZE 0 0 ALLCAP NODIGIT 0 0 0 0 0 0 0 0 11 11 ()(://.///./). 14 7 1 1 0 0 1

